<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS One</journal-id><journal-id journal-id-type="iso-abbrev">PLoS ONE</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><journal-title-group><journal-title>PLoS ONE</journal-title></journal-title-group><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, CA USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">26517867</article-id><article-id pub-id-type="pmc">4627811</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0141256</article-id><article-id pub-id-type="publisher-id">PONE-D-15-24522</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Effects of High-Intensity Interval Training versus Continuous Training on Physical Fitness, Cardiovascular Function and Quality of Life in Heart Failure Patients</article-title><alt-title alt-title-type="running-head">Interval Training versus Continuous Training in Heart Failure</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Benda</surname><given-names>Nathalie M. M.</given-names></name><xref ref-type="aff" rid="aff001">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Seeger</surname><given-names>Joost P. H.</given-names></name><xref ref-type="aff" rid="aff001">
<sup>1</sup>
</xref><xref ref-type="aff" rid="aff004">
<sup>4</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Stevens</surname><given-names>Guus G. C. F.</given-names></name><xref ref-type="aff" rid="aff001">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Hijmans-Kersten</surname><given-names>Bregina T. P.</given-names></name><xref ref-type="aff" rid="aff001">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>van Dijk</surname><given-names>Arie P. J.</given-names></name><xref ref-type="aff" rid="aff002">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Bellersen</surname><given-names>Louise</given-names></name><xref ref-type="aff" rid="aff002">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Lamfers</surname><given-names>Evert J. P.</given-names></name><xref ref-type="aff" rid="aff003">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Hopman</surname><given-names>Maria T. E.</given-names></name><xref ref-type="aff" rid="aff001">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Thijssen</surname><given-names>Dick H. J.</given-names></name><xref ref-type="aff" rid="aff001">
<sup>1</sup>
</xref><xref ref-type="aff" rid="aff004">
<sup>4</sup>
</xref><xref rid="cor001" ref-type="corresp">*</xref></contrib></contrib-group><aff id="aff001">
<label>1</label>
<addr-line>Radboud university medical center, Radboud Institute for Health Sciences, Department of Physiology, Nijmegen, the Netherlands</addr-line>
</aff><aff id="aff002">
<label>2</label>
<addr-line>Radboud university medical center, Radboud Institute for Health Sciences, Department of Cardiology, Nijmegen, the Netherlands</addr-line>
</aff><aff id="aff003">
<label>3</label>
<addr-line>Canisius-Wilhelmina Hospital, Department of Cardiology, Nijmegen, the Netherlands</addr-line>
</aff><aff id="aff004">
<label>4</label>
<addr-line>Liverpool John Moores University, Research Institute for Sport and Exercise Sciences, Liverpool, United Kingdom</addr-line>
</aff><contrib-group><contrib contrib-type="editor"><name><surname>Hosoda</surname><given-names>Toru</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1">
<addr-line>Tokai University, JAPAN</addr-line>
</aff><author-notes><fn fn-type="COI-statement" id="coi001"><p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p></fn><fn fn-type="con" id="contrib001"><p>Conceived and designed the experiments: NMMB JPHS APJD MTEH DHJT. Performed the experiments: NMMB JPHS GGCFS BTPH APJD DHJT. Analyzed the data: NMMB JPHS GGCFS BTPH APJD DHJT. Wrote the paper: NMMB JPHS GGCFS BTPH APJD LB EJPL MTEH DHJT. Recruitment of participants: NMMB JPHS APJD LB EJPL. Interpretation of results: NMMB APJD MTEH DHJT.</p></fn><corresp id="cor001">* E-mail: <email>dick.thijssen@radboudumc.nl</email></corresp></author-notes><pub-date pub-type="epub"><day>30</day><month>10</month><year>2015</year></pub-date><pub-date pub-type="collection"><year>2015</year></pub-date><volume>10</volume><issue>10</issue><elocation-id>e0141256</elocation-id><history><date date-type="received"><day>14</day><month>7</month><year>2015</year></date><date date-type="accepted"><day>5</day><month>10</month><year>2015</year></date></history><permissions><copyright-statement>&#x000a9; 2015 Benda et al</copyright-statement><copyright-year>2015</copyright-year><copyright-holder>Benda et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:type="simple" xlink:href="pone.0141256.pdf"/><abstract><sec id="sec001"><title>Introduction</title><p>Physical fitness is an important prognostic factor in heart failure (HF). To improve fitness, different types of exercise have been explored, with recent focus on high-intensity interval training (HIT). We comprehensively compared effects of HIT <italic>versus</italic> continuous training (CT) in HF patients NYHA II-III on physical fitness, cardiovascular function and structure, and quality of life, and hypothesize that HIT leads to superior improvements compared to CT.</p></sec><sec id="sec002"><title>Methods</title><p>Twenty HF patients (male:female 19:1, 64&#x000b1;8 yrs, ejection fraction 38&#x000b1;6%) were allocated to 12-weeks of HIT (10*1-minute at 90% maximal workload&#x02014;alternated by 2.5 minutes at 30% maximal workload) or CT (30 minutes at 60&#x02013;75% of maximal workload). Before and after intervention, we examined physical fitness (incremental cycling test), cardiac function and structure (echocardiography), vascular function and structure (ultrasound) and quality of life (SF-36, Minnesota living with HF questionnaire (MLHFQ)).</p></sec><sec id="sec003"><title>Results</title><p>Training improved maximal workload, peak oxygen uptake (VO<sub>2peak</sub>) related to the predicted VO<sub>2peak</sub>, oxygen uptake at the anaerobic threshold, and maximal oxygen pulse (all <italic>P</italic>&#x0003c;0.05), whilst no differences were present between HIT and CT (N.S.). We found no major changes in resting cardiovascular function and structure. SF-36 physical function score improved after training (<italic>P</italic>&#x0003c;0.05), whilst SF-36 total score and MLHFQ did not change after training (N.S.).</p></sec><sec id="sec004"><title>Conclusion</title><p>Training induced significant improvements in parameters of physical fitness, although no evidence for superiority of HIT over CT was demonstrated. No major effect of training was found on cardiovascular structure and function or quality of life in HF patients NYHA II-III.</p></sec><sec id="sec005"><title>Trial Registration</title><p>Nederlands Trial Register <ext-link ext-link-type="uri" xlink:href="http://www.trialregister.nl/trialreg/admin/rctview.asp?TC=3671">NTR3671</ext-link>
</p></sec></abstract><funding-group><funding-statement>DHJT is financially supported by the Netherlands Heart Foundation (E Dekker-stipend, 2009T064).</funding-statement></funding-group><counts><fig-count count="1"/><table-count count="5"/><page-count count="16"/></counts><custom-meta-group><custom-meta id="data-availability"><meta-name>Data Availability</meta-name><meta-value>All relevant data are within the paper and its Supporting Information files.</meta-value></custom-meta></custom-meta-group></article-meta><notes><title>Data Availability</title><p>All relevant data are within the paper and its Supporting Information files.</p></notes></front><body><sec sec-type="intro" id="sec006"><title>Introduction</title><p>Heart failure (HF) is a common disease with an increasing prevalence worldwide [<xref rid="pone.0141256.ref001" ref-type="bibr">1</xref>], and is characterized by a low 5-year survival of 35&#x02013;55% [<xref rid="pone.0141256.ref002" ref-type="bibr">2</xref>&#x02013;<xref rid="pone.0141256.ref004" ref-type="bibr">4</xref>]. Several studies have indicated that physical fitness is an important prognostic factor for HF patients, in which a low physical fitness is associated with higher mortality rates [<xref rid="pone.0141256.ref005" ref-type="bibr">5</xref>,<xref rid="pone.0141256.ref006" ref-type="bibr">6</xref>]. Previous studies demonstrate that exercise training can improve physical fitness [<xref rid="pone.0141256.ref007" ref-type="bibr">7</xref>], cardiac function [<xref rid="pone.0141256.ref008" ref-type="bibr">8</xref>], vascular function [<xref rid="pone.0141256.ref009" ref-type="bibr">9</xref>,<xref rid="pone.0141256.ref010" ref-type="bibr">10</xref>], and quality of life [<xref rid="pone.0141256.ref007" ref-type="bibr">7</xref>] in HF patients [<xref rid="pone.0141256.ref011" ref-type="bibr">11</xref>]. Therefore, exercise training is recommended for HF patients and encompasses a central component of cardiac rehabilitation [<xref rid="pone.0141256.ref012" ref-type="bibr">12</xref>].</p><p>Most previous studies examining the impact of exercise training in HF patients have adopted exercise at moderate-intensity. Recent studies explored the impact of high-intensity interval training (HIT), which can be described as short periods of exercise performed at high-intensity (&#x0003e;80&#x02013;85% peak oxygen uptake [<xref rid="pone.0141256.ref013" ref-type="bibr">13</xref>&#x02013;<xref rid="pone.0141256.ref015" ref-type="bibr">15</xref>]), alternated by periods of active or passive rest. Wisl&#x000f8;ff <italic>et al</italic>. suggested a superior effect of HIT compared to continuous training (CT) on physical fitness, cardiovascular function and quality of life in HF patients [<xref rid="pone.0141256.ref016" ref-type="bibr">16</xref>]. This study applied an intensive HIT training regimen in HF patients and found large improvements in fitness levels. After this promising study, Fu <italic>et al</italic>. found similar results [<xref rid="pone.0141256.ref017" ref-type="bibr">17</xref>], but not all subsequent studies [<xref rid="pone.0141256.ref018" ref-type="bibr">18</xref>&#x02013;<xref rid="pone.0141256.ref022" ref-type="bibr">22</xref>], reinforced the superior effect of HIT compared to CT in HF patients.</p><p>Previous studies that revealed a superior effect of HIT adopted relatively long bouts of high-intensity exercise (3&#x02013;4 min) [<xref rid="pone.0141256.ref016" ref-type="bibr">16</xref>,<xref rid="pone.0141256.ref017" ref-type="bibr">17</xref>], followed by active &#x02018;rest&#x02019; periods of 3 minutes at an intensity up to 70% of maximal heart rate. Performance of such long bouts of exercise at high-intensity and/or &#x02018;rest&#x02019; periods at such vigorous intensity levels may not be feasible for all HF patients. Furthermore, most previous training studies have applied a training frequency of three times per week, which is time consuming. Whilst training frequencies of twice per week can be sufficient to induce a positive effect on fitness levels [<xref rid="pone.0141256.ref023" ref-type="bibr">23</xref>], no previous study examined the efficacy of HIT with lower training frequency or whether there is a difference between such HIT and CT training protocols. Therefore, we explored the benefits of a feasible HIT-protocol with high-intensity bouts of moderate duration (i.e. 1 min), the active rest at relatively low intensity (i.e. 30% maximal workload), and a training frequency of twice a week.</p><p>In this study, we examined whether 12-weeks of CT or HIT is effective and feasible for HF patients, and whether this HIT-protocol leads to superior effects on fitness, cardiovascular function and quality of life compared to CT. We hypothesize that the HIT-protocol is feasible, whilst the effects on physical fitness, cardiovascular function and quality of life in HF patients New York Heart Association (NYHA) class II-III are superior compared to CT.</p></sec><sec sec-type="materials|methods" id="sec007"><title>Methods</title><sec id="sec008"><title>Subjects</title><p>We included 29 patients (65&#x000b1;8 yrs) diagnosed with HF classified as NYHA class II-III, with a history of left ventricular ejection fraction (LVEF) &#x02264;45% (assessed by 2D/4D echocardiography). Patients were recruited from the department of Cardiology of the Radboud university medical center and the Canisius-Wilhelmina Hospital (Nijmegen, the Netherlands) and through advertisements. Patients with HF due to congenital heart disease or HF caused by valve pathology were excluded. Other exclusion criteria were: diabetes mellitus (type 1 or 2), hypercholesterolemia (total cholesterol &#x0003e;6.5mmol/L), severe renal failure (glomerular filtration rate&#x0003c;30 mL/min/1.73m<sup>2</sup>), exercise-induced ischemia (i.e. ECG abnormalities suggestive for ischemia on maximal exercise testing), severe co-morbidities (e.g. COPD GOLD &#x02265;3), pathology that restricts patients from participation to exercise (e.g. orthopedic/neurological disorders interfering with movement), pre-menopausal women or women on hormone replacement therapy, and subjects with contra-indications for maximal exercise testing [<xref rid="pone.0141256.ref024" ref-type="bibr">24</xref>]. Subjects had to be in a clinically and pharmacologically stable situation (&#x0003e;3 months) prior to participation. The Medical Ethical Committee of the Radboud university medical center approved this study (CMO region Arnhem-Nijmegen) on October 26<sup>th</sup> 2010. This trial is registered in the Dutch Trial Register (NTR3671) 3 months after the start due to practical reasons. The authors confirm that all ongoing and related trials for this intervention are registered. Written informed consent was obtained from each subject before participation in this study. Subject recruitment was done between July 2011 and September 2014. Follow-up lasted until February 2015. This study was monitored by a data safety monitoring board, which also approved the submission of this study.</p></sec><sec id="sec009"><title>Experimental protocol</title><p>Subjects reported to our laboratory for a medical screening, after which they were allocated to 12-weeks moderate-intensity CT or HIT. In addition, to assess changes over time in HF patients, we included a control group consisting of HF patients who were unable to participate in the training program due to geographical reasons or time-constraints, which was tested before and after a 12-week control period. Before and after the 12-week intervention/control period, subjects underwent a maximal incremental cycling test to determine physical fitness, echocardiography to examine cardiac function and structure, and vascular ultrasound measurements to examine peripheral artery vascular function and structure. Finally, questionnaires were used before and after the intervention to assess health-related quality of life and HF symptoms. All measurements were performed in the Radboud university medical center (Nijmegen, the Netherlands). Due to the nature of the study design and practical reasons, blinding participants and researchers was not possible.</p></sec><sec id="sec010"><title>Measurements</title><sec id="sec011"><title>Subject characteristics</title><p>We determined height, weight (Seca 888 Scale, Seca, Hamburg, Germany), body mass index, body fat percentage [<xref rid="pone.0141256.ref025" ref-type="bibr">25</xref>], and waist and hip circumference. Furthermore, we obtained heart rate and blood pressure (manually, WelchAllyn, Maxi-Stabil 3, NY, USA), an electrocardiogram to determine heart rhythm, and a venous blood sample to determine fasted glucose and (total) cholesterol concentrations.</p></sec><sec id="sec012"><title>Primary outcome&#x02014;Physical fitness</title><p>An incremental maximal cycling test was performed on a cycle ergometer (Ergoline, Ergoselect 200k, Bitz, Germany). Subjects were instructed to pedal (&#x0003e;60rpm) whilst workload was increased 10&#x02013;15 Watt/min, depending on the expected physical fitness of the participant (based on sex, age, height, and previous results on exercise testing). During exercise, breath-by-breath gas analysis was recorded continuously (LabManager V5.32.0). For the termination of maximal exercise testing we adhered to recent guidelines [<xref rid="pone.0141256.ref024" ref-type="bibr">24</xref>]. Peak oxygen uptake (VO<sub>2peak</sub>) was defined as the highest oxygen uptake (30-second average).</p></sec><sec id="sec013"><title>Secondary outcome&#x02014;Physical fitness</title><p>Oxygen uptake at the anaerobic threshold (AT) was determined using the V-slope method [<xref rid="pone.0141256.ref026" ref-type="bibr">26</xref>]. Peak oxygen uptake and oxygen uptake at the AT was also expressed as a percentage of the predicted maximal oxygen consumption [<xref rid="pone.0141256.ref027" ref-type="bibr">27</xref>]. Ventilatory efficiency was defined as the slope of the ventilation to the carbon dioxide production (VE/VCO<sub>2</sub> slope) calculated over the linear phase of the response up to the AT. The maximal oxygen pulse (oxygen consumption per heart rate, O<sub>2</sub>/HR) was determined (10-second average). The presence of chronotropic incompetence, defined as a heart rate reserve &#x0003c;80% of predicted [<xref rid="pone.0141256.ref028" ref-type="bibr">28</xref>], was noted. Prior to testing, all medication was continued.</p></sec><sec id="sec014"><title>Secondary outcome&#x02014;Vascular function and structure</title><p>Subjects were prepared according to guidelines for the assessment of flow-mediated dilation (FMD) [<xref rid="pone.0141256.ref029" ref-type="bibr">29</xref>]. Subjects were instructed to continue medication, but to refrain from diuretics the day of testing for practical reasons. The measurements were performed in a temperature-controlled room (22.5&#x000b1;0.7&#x000b0;C). Prior to testing, subjects rested in the supine position for 10 minutes. Vascular function measurements were performed using a 10-MHz multifrequency linear array probe attached to a high-resolution ultrasound machine (Terason T3000, Burlington, MA, USA). We examined brachial and superficial femoral artery endothelial function using the FMD according to the guidelines [<xref rid="pone.0141256.ref029" ref-type="bibr">29</xref>]. Subsequently, we measured the brachial artery maximal diameter and blood flow responses to ischemic handgrip exercise, as described in previous studies [<xref rid="pone.0141256.ref030" ref-type="bibr">30</xref>,<xref rid="pone.0141256.ref031" ref-type="bibr">31</xref>]. The peak blood flow provides a valid and accepted index of resistance artery size and remodelling and the brachial artery diameter response for maximal dilating capacity [<xref rid="pone.0141256.ref030" ref-type="bibr">30</xref>]. We examined carotid artery intima-media thickness (IMT), which represents a surrogate measure for atherosclerosis [<xref rid="pone.0141256.ref032" ref-type="bibr">32</xref>]. Finally, we examined the endothelium-independent dilation of the brachial artery by examining the diameter response to an exogenous nitric oxide donor (sublingual administration of 400&#x003bc;g glyceryl trinitrate (GTN)).</p></sec><sec id="sec015"><title>Secondary outcome&#x02014;Cardiac function</title><p>Transthoracic (4D) echocardiography was performed with an ultrasound scanner (Vivid E9, General Electric Healthcare, Horten, Norway) with M5-S and V4 probe according to the guidelines of the American Society of Echocardiography [<xref rid="pone.0141256.ref033" ref-type="bibr">33</xref>]. Echocardiographic images were analyzed post-hoc with EchoPAC software (version 112, General Electric Healthcare, Horten, Norway). From 4D-images we assessed: left ventricular end-diastolic volume, left ventricular end-systolic volume, stroke volume, LVEF, cardiac output, and cardiac index. Left ventricular longitudinal, circumferential, radial, and area strain were analyzed by 4D speckle tracking. Moreover, we measured the isovolumetric contraction and relaxation time from tissue Doppler tracings of the lateral and septal mitral annulus. To describe diastolic function we obtained the following parameters by (tissue) pulsed-wave Doppler tracings: peak mitral flow velocity during early (E) and late (A) diastole, the systolic (S) and diastolic (D) inflow velocity over the pulmonary valve, and the peak mitral annulus velocity during early filling (E&#x02019;) of the lateral and septal mitral annulus. The E/A-ratio, S/D-ratio, and E/E&#x02019;-ratio were calculated.</p></sec><sec id="sec016"><title>Secondary outcome&#x02013;Questionnaires</title><p>To measure health-related quality of life, the SF-36 Health Survey was used [<xref rid="pone.0141256.ref034" ref-type="bibr">34</xref>,<xref rid="pone.0141256.ref035" ref-type="bibr">35</xref>]. Additionally, we used the Minnesota living with Heart Failure Questionnaire (MLHFQ), to measure patient perceptions of the effects of HF on their physical, psychological and socioeconomic lives [<xref rid="pone.0141256.ref036" ref-type="bibr">36</xref>].</p></sec></sec><sec id="sec017"><title>12-week intervention</title><p>Training was performed twice a week for 12 weeks in a rehabilitation setting or hospital and was supervised by physiotherapists. When a participant missed a training session, this session was rescheduled to ensure a total of 24 training sessions (i.e. 100% compliance). Training was performed on a cycle ergometer (Lode Corival, Procare, Groningen, The Netherlands). Both the CT- and HIT-session started with a warm-up of 10-minutes at 40% of maximal workload (Watt) as obtained from the cardiopulmonary maximal exercise test at baseline, and concluded with a cooling-down of 5-minutes at 30% of maximal workload. Workload was increased during the 12-week training period based on the Borg scores of perceived exertion, to maintain a sufficient training stimulus when physical fitness was expected to improve.</p><sec id="sec018"><title>CT-group</title><p>CT consisted of 30-minutes at 60&#x02013;75% of maximal workload. Training intensity was controlled using the Borg score (scale 6&#x02013;20) [<xref rid="pone.0141256.ref037" ref-type="bibr">37</xref>], aiming at a Borg score of 12&#x02013;14 during the training session, as recommended in the current exercise guidelines for HF patients [<xref rid="pone.0141256.ref012" ref-type="bibr">12</xref>]. Borg score and heart rate were determined after the warm-up, at 20, 30 and 40 minutes of exercise, and after the cooling-down.</p></sec><sec id="sec019"><title>HIT-group</title><p>HIT consisted of 10 periods of 3.5-minutes of exercise, consisting of intervals of 1-minute at 90% of maximal workload, and 2.5-minutes at 30% of maximal workload, aiming at a Borg score of 15&#x02013;17 during the high-intensity intervals. Borg score and heart rate were determined at the end of the warm-up, after repetition 1, 3, 7 and 10, and after the cooling-down.</p></sec><sec id="sec020"><title>Control group</title><p>Control subjects were instructed not to alter their daily physical activities.</p></sec></sec><sec id="sec021"><title>Statistical analysis</title><p>We have made a pre-study sample size calculation based on previous studies examining the difference in effect between CT and HIT. Some studies suggest n = 2&#x02013;3 per group is sufficient [<xref rid="pone.0141256.ref016" ref-type="bibr">16</xref>,<xref rid="pone.0141256.ref017" ref-type="bibr">17</xref>], whilst data from others suggest several thousand subjects must be recruited to detect differences between CT and HIT [<xref rid="pone.0141256.ref019" ref-type="bibr">19</xref>]. We rationalized that n = 10&#x02013;20 will provide (clinically) meaningful insight into the effect of CT <italic>versus</italic> HIT. Therefore, using a conservative approach (accounting for drop-outs), we aimed for n = 20 for both exercise training groups (and n = 10 in the control group). Data was analyzed using IBM SPSS Statistics 20.0 (IBM Corp., Armonk, NY, USA). Parameters were checked for normality using a Kolmogorov-Smirnov test. When data was not normally distributed, a non-parametric alternative was used or natural logarithmic data transformation was applied. Categorical and nominal parameters were compared with a Chi-Square test. Baseline characteristics of the groups were compared with a 1-way ANOVA or Kruskal-Wallis test when data was not normally distributed. A 2-way repeated measures ANOVA was used to examine the impact of exercise training (time-effect), and whether the change differs between HIT and CT (time*group-effect). When a significant main effect (time) or interaction-effect (time*group) was observed, post-hoc tests with least-significant difference were used to identify differences between and within groups. When data for this 2-way comparison was not normally distributed, we used individual tests to examine the effect of time, group and time*group. Changes in the control group were tested with a paired Student&#x02019;s <italic>t</italic>-test, or Wilcoxon test when data was not normally distributed. To control for the potential impact of baseline diameter on FMD [<xref rid="pone.0141256.ref038" ref-type="bibr">38</xref>], we used logarithmically transformed diameter data and adopted a univariate General Linear Model with baseline arterial diameter as a covariate, to compare differences between groups. Potential drop-outs were left out of the analysis and were not replaced. A Pearson correlation coefficient was determined for the relation between baseline quality of life and exercise-induced changes in quality of life. Data are presented as mean&#x000b1;standard deviation (SD), unless stated otherwise. Significance level was set at P&#x0003c;0.05.</p></sec></sec><sec sec-type="results" id="sec022"><title>Results</title><p>For this study, 59 HF patients were screened. Fifteen patients did not meet inclusion criteria (screen failures) and 11 patients declined to participate after screening due to lack of time (n = 10) or change in health (n = 1) (<xref rid="pone.0141256.g001" ref-type="fig">Fig 1</xref>). We allocated 24 patients to HIT or CT. Nine HF patients were included in the control group (non-randomized). In both the HIT- and CT-group, 2 drop-outs were reported after allocation (71&#x000b1;2yrs; male:female 3:1; NYHA class II:III 3:1), which makes the total drop-out 17%. A patient in both training groups dropped out due to musculoskeletal complaints and a patient in both training groups dropped out due to progression of HF. Twenty patients in the training-groups and nine controls completed the study and were available for final analysis. The groups were not significantly different in age, body mass index, NYHA class, etiology of HF, blood pressure, heart rate, LVEF and physical fitness (<xref rid="pone.0141256.t001" ref-type="table">Table 1</xref>). The control group consisted of significantly more females than the CT-group (P = 0.028, <xref rid="pone.0141256.t001" ref-type="table">Table 1</xref>). Cardiovascular medication use is documented in <xref rid="pone.0141256.t001" ref-type="table">Table 1</xref>.</p><fig id="pone.0141256.g001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0141256.g001</object-id><label>Fig 1</label><caption><title>Flow-chart of the inclusion of subjects.</title></caption><graphic xlink:href="pone.0141256.g001"/></fig><table-wrap id="pone.0141256.t001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0141256.t001</object-id><label>Table 1</label><caption><title>Subject characteristics and cardiovascular medication.</title></caption><alternatives><graphic id="pone.0141256.t001g" xlink:href="pone.0141256.t001"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">CT (n = 10)</th><th align="center" rowspan="1" colspan="1">HIT (n = 10)</th><th align="center" rowspan="1" colspan="1">Control (n = 9)</th><th align="left" rowspan="1" colspan="1"/></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Age (yrs)</td><td align="center" rowspan="1" colspan="1">64&#x000b1;8</td><td align="center" rowspan="1" colspan="1">63&#x000b1;8</td><td align="center" rowspan="1" colspan="1">67&#x000b1;7</td><td align="center" rowspan="1" colspan="1">0.57</td></tr><tr><td align="left" rowspan="1" colspan="1">Sex (male:female)</td><td align="center" rowspan="1" colspan="1">10:0<xref rid="t001fn003" ref-type="table-fn">*</xref>
</td><td align="center" rowspan="1" colspan="1">9:1</td><td align="center" rowspan="1" colspan="1">5:4</td><td align="center" rowspan="1" colspan="1">0.028</td></tr><tr><td align="left" rowspan="1" colspan="1">Body weight (kg)</td><td align="center" rowspan="1" colspan="1">89.7&#x000b1;11.9</td><td align="center" rowspan="1" colspan="1">87.6&#x000b1;23.6</td><td align="center" rowspan="1" colspan="1">77.0&#x000b1;10.5</td><td align="center" rowspan="1" colspan="1">0.16</td></tr><tr><td align="left" rowspan="1" colspan="1">Height (cm)</td><td align="center" rowspan="1" colspan="1">177&#x000b1;5</td><td align="center" rowspan="1" colspan="1">177&#x000b1;3</td><td align="center" rowspan="1" colspan="1">174&#x000b1;9</td><td align="center" rowspan="1" colspan="1">0.66</td></tr><tr><td align="left" rowspan="1" colspan="1">Body mass index (kg/m<sup>2</sup>)</td><td align="center" rowspan="1" colspan="1">28.9&#x000b1;4.7</td><td align="center" rowspan="1" colspan="1">28.1&#x000b1;7.5</td><td align="center" rowspan="1" colspan="1">25.4&#x000b1;2.7</td><td align="center" rowspan="1" colspan="1">0.24</td></tr><tr><td align="left" rowspan="1" colspan="1">NYHA class (II:III)</td><td align="center" rowspan="1" colspan="1">8:2</td><td align="center" rowspan="1" colspan="1">8:2</td><td align="center" rowspan="1" colspan="1">8:1</td><td align="center" rowspan="1" colspan="1">0.84</td></tr><tr><td align="left" rowspan="1" colspan="1">Etiology (Isch:Non-isch)</td><td align="center" rowspan="1" colspan="1">8:2</td><td align="center" rowspan="1" colspan="1">7:3</td><td align="center" rowspan="1" colspan="1">5:4</td><td align="center" rowspan="1" colspan="1">0.51</td></tr><tr><td align="left" rowspan="1" colspan="1">Systolic blood pressure (mmHg)</td><td align="center" rowspan="1" colspan="1">132&#x000b1;23</td><td align="center" rowspan="1" colspan="1">132&#x000b1;18</td><td align="center" rowspan="1" colspan="1">130&#x000b1;25</td><td align="center" rowspan="1" colspan="1">0.98</td></tr><tr><td align="left" rowspan="1" colspan="1">Diastolic blood pressure (mmHg)</td><td align="center" rowspan="1" colspan="1">83&#x000b1;11</td><td align="center" rowspan="1" colspan="1">79&#x000b1;10</td><td align="center" rowspan="1" colspan="1">78&#x000b1;14</td><td align="center" rowspan="1" colspan="1">0.48</td></tr><tr><td align="left" rowspan="1" colspan="1">Resting heart rate (/min)</td><td align="center" rowspan="1" colspan="1">59&#x000b1;11</td><td align="center" rowspan="1" colspan="1">57&#x000b1;7</td><td align="center" rowspan="1" colspan="1">60&#x000b1;10</td><td align="center" rowspan="1" colspan="1">0.80</td></tr><tr><td align="left" rowspan="1" colspan="1">Maximal heart rate (/min)<xref rid="t001fn002" ref-type="table-fn">
<sup>&#x02020;</sup>
</xref>
</td><td align="center" rowspan="1" colspan="1">129&#x000b1;19</td><td align="center" rowspan="1" colspan="1">126&#x000b1;16</td><td align="center" rowspan="1" colspan="1">120&#x000b1;15</td><td align="center" rowspan="1" colspan="1">0.53</td></tr><tr><td align="left" rowspan="1" colspan="1">Chronotropic incompetence (yes:no)<xref rid="t001fn002" ref-type="table-fn">
<sup>&#x02020;</sup>
</xref>
</td><td align="center" rowspan="1" colspan="1">5:4</td><td align="center" rowspan="1" colspan="1">8:2</td><td align="center" rowspan="1" colspan="1">6:1</td><td align="center" rowspan="1" colspan="1">0.33</td></tr><tr><td align="left" rowspan="1" colspan="1">VO<sub>2peak</sub>
<xref rid="t001fn002" ref-type="table-fn">
<sup>&#x02020;</sup>
</xref> (mL/min/kg)</td><td align="center" rowspan="1" colspan="1">21.0&#x000b1;3.4</td><td align="center" rowspan="1" colspan="1">19.1&#x000b1;4.1</td><td align="center" rowspan="1" colspan="1">17.4&#x000b1;5.8</td><td align="center" rowspan="1" colspan="1">0.26</td></tr><tr><td align="left" rowspan="1" colspan="1">VO<sub>2peak</sub>
<xref rid="t001fn002" ref-type="table-fn">
<sup>&#x02020;</sup>
</xref> (% of predicted VO<sub>2peak</sub>)</td><td align="center" rowspan="1" colspan="1">86&#x000b1;8</td><td align="center" rowspan="1" colspan="1">79&#x000b1;17</td><td align="center" rowspan="1" colspan="1">81&#x000b1;22</td><td align="center" rowspan="1" colspan="1">0.63</td></tr><tr><td align="left" rowspan="1" colspan="1">LVEF (%)</td><td align="center" rowspan="1" colspan="1">38&#x000b1;6</td><td align="center" rowspan="1" colspan="1">37&#x000b1;6</td><td align="center" rowspan="1" colspan="1">40&#x000b1;11</td><td align="center" rowspan="1" colspan="1">0.84</td></tr><tr><td align="left" rowspan="1" colspan="1">Medication</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Angiotensin converting enzyme-inhibitors</td><td align="center" rowspan="1" colspan="1">5 (50%)</td><td align="center" rowspan="1" colspan="1">6 (60%)</td><td align="center" rowspan="1" colspan="1">8 (89%)</td><td align="center" rowspan="1" colspan="1">0.19</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Angiotensin II receptor antagonists</td><td align="center" rowspan="1" colspan="1">4 (40%)</td><td align="center" rowspan="1" colspan="1">4 (40%)</td><td align="center" rowspan="1" colspan="1">1 (11%)</td><td align="center" rowspan="1" colspan="1">0.30</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Aldosterone antagonist</td><td align="center" rowspan="1" colspan="1">6 (60%)</td><td align="center" rowspan="1" colspan="1">7 (70%)</td><td align="center" rowspan="1" colspan="1">8 (89%)</td><td align="center" rowspan="1" colspan="1">0.36</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Diuretics (loopdiuretics)</td><td align="center" rowspan="1" colspan="1">7 (70%)</td><td align="center" rowspan="1" colspan="1">6 (60%)</td><td align="center" rowspan="1" colspan="1">4 (44%)</td><td align="center" rowspan="1" colspan="1">0.50</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x003b2;-blockers</td><td align="center" rowspan="1" colspan="1">10 (100%)</td><td align="center" rowspan="1" colspan="1">9 (90%)</td><td align="center" rowspan="1" colspan="1">9 (100%)</td><td align="center" rowspan="1" colspan="1">0.37</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Antiplatelet drugs</td><td align="center" rowspan="1" colspan="1">6 (60%)</td><td align="center" rowspan="1" colspan="1">4 (40%)</td><td align="center" rowspan="1" colspan="1">3 (33%)</td><td align="center" rowspan="1" colspan="1">0.47</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Coumarin derivates</td><td align="center" rowspan="1" colspan="1">4 (40%)</td><td align="center" rowspan="1" colspan="1">7 (70%)</td><td align="center" rowspan="1" colspan="1">4 (44%)</td><td align="center" rowspan="1" colspan="1">0.35</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Statins</td><td align="center" rowspan="1" colspan="1">10 (100%)</td><td align="center" rowspan="1" colspan="1">9 (90%)</td><td align="center" rowspan="1" colspan="1">4 (44%)<xref rid="t001fn004" ref-type="table-fn">
<sup>&#x000a7;</sup>
</xref>
</td><td align="center" rowspan="1" colspan="1">0.007</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t001fn001"><p>Data is presented as mean&#x000b1;SD. P-values refer to a 1-way ANOVA.</p></fn><fn id="t001fn002"><p>
<sup>&#x02020;</sup> Data was unavailable for 1 subject in the CT-group and 3 subjects in the control-group.</p></fn><fn id="t001fn003"><p>* Significantly less females compared to the control-group.</p></fn><fn id="t001fn004"><p>
<sup>&#x000a7;</sup>Lower compared to CT-group and HIT-group.</p></fn></table-wrap-foot></table-wrap><sec id="sec023"><title>Exercise training</title><p>When averaging all training sessions, CT was performed at 66&#x000b1;5% of maximal workload, whilst the high-intensity intervals during HIT were performed at 102&#x000b1;7% of maximal workload (P&#x0003c;0.001). CT was performed at 81&#x000b1;7% of maximal heart rate, and the high-intensity intervals during HIT were performed at 83&#x000b1;9% of maximal heart rate (P = 0.70). Borg-scores during CT and HIT were 13&#x000b1;1 and 14&#x000b1;1 respectively (P = 0.27).</p></sec><sec id="sec024"><title>Impact of exercise training</title><sec id="sec025"><title>Physical fitness</title><p>VO<sub>2peak</sub> tended to increase after training (P = 0.06), whilst VO<sub>2peak</sub>/kg did not change after exercise (P = 0.10). A significant increase after training was found in the VO<sub>2peak</sub> related to predicted VO<sub>2peak</sub> (%), maximal workload, oxygen uptake at the AT and maximal oxygen pulse (<xref rid="pone.0141256.t002" ref-type="table">Table 2</xref>). No significant differences were observed between both interventions (<xref rid="pone.0141256.t002" ref-type="table">Table 2</xref>).</p><table-wrap id="pone.0141256.t002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0141256.t002</object-id><label>Table 2</label><caption><title>Maximal incremental cycling test.</title></caption><alternatives><graphic id="pone.0141256.t002g" xlink:href="pone.0141256.t002"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">CT (n = 10)</th><th colspan="2" align="center" rowspan="1"/><th align="center" rowspan="1" colspan="1">HIT (n = 10)</th><th align="center" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">P-value</th><th align="center" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1"/></tr><tr><th align="left" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">
<italic>Pre</italic>
</th><th align="center" rowspan="1" colspan="1">
<italic>Post</italic>
</th><th colspan="2" align="center" rowspan="1">
<italic>Pre</italic>
</th><th align="center" rowspan="1" colspan="1">
<italic>Post</italic>
</th><th align="center" rowspan="1" colspan="1">
<italic>Time</italic>
</th><th align="center" rowspan="1" colspan="1">
<italic>Group</italic>
</th><th align="center" rowspan="1" colspan="1">
<italic>Time*Group</italic>
</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">VO<sub>2peak</sub> (mL/min)</td><td align="center" rowspan="1" colspan="1">1881&#x000b1;214</td><td align="center" rowspan="1" colspan="1">1887&#x000b1;27</td><td colspan="2" align="center" rowspan="1">1662&#x000b1;562</td><td align="center" rowspan="1" colspan="1">1792&#x000b1;559</td><td align="center" rowspan="1" colspan="1">0.06</td><td align="center" rowspan="1" colspan="1">0.44</td><td align="center" rowspan="1" colspan="1">0.08</td></tr><tr><td align="left" rowspan="1" colspan="1">VO<sub>2peak</sub> (mL/min/kg)</td><td align="center" rowspan="1" colspan="1">21.2&#x000b1;3.6</td><td align="center" rowspan="1" colspan="1">21.3&#x000b1;3.7</td><td colspan="2" align="center" rowspan="1">19.1&#x000b1;4.1</td><td align="center" rowspan="1" colspan="1">20.4&#x000b1;4.3</td><td align="center" rowspan="1" colspan="1">0.10</td><td align="center" rowspan="1" colspan="1">0.14</td><td align="center" rowspan="1" colspan="1">0.09<xref rid="t002fn002" ref-type="table-fn">
<sup>#</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">VO<sub>2peak</sub> (% pred. VO<sub>2peak</sub>)</td><td align="center" rowspan="1" colspan="1">86&#x000b1;8</td><td align="center" rowspan="1" colspan="1">87&#x000b1;10</td><td colspan="2" align="center" rowspan="1">79&#x000b1;17</td><td align="center" rowspan="1" colspan="1">85&#x000b1;16</td><td align="center" rowspan="1" colspan="1">0.044</td><td align="center" rowspan="1" colspan="1">0.48</td><td align="center" rowspan="1" colspan="1">0.08</td></tr><tr><td align="left" rowspan="1" colspan="1">Max. workload (Watt)</td><td align="center" rowspan="1" colspan="1">145&#x000b1;22</td><td align="center" rowspan="1" colspan="1">152&#x000b1;26</td><td colspan="2" align="center" rowspan="1">126&#x000b1;38</td><td align="center" rowspan="1" colspan="1">142&#x000b1;45</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001</td><td align="center" rowspan="1" colspan="1">0.24</td><td align="center" rowspan="1" colspan="1">0.07</td></tr><tr><td align="left" rowspan="1" colspan="1">Max. heart rate (/min)</td><td align="center" rowspan="1" colspan="1">129&#x000b1;19</td><td align="center" rowspan="1" colspan="1">132&#x000b1;24</td><td colspan="2" align="center" rowspan="1">126&#x000b1;16</td><td align="center" rowspan="1" colspan="1">125&#x000b1;15</td><td align="center" rowspan="1" colspan="1">0.78</td><td align="center" rowspan="1" colspan="1">0.30</td><td align="center" rowspan="1" colspan="1">0.51</td></tr><tr><td align="left" rowspan="1" colspan="1">VE/VCO<sub>2</sub> slope</td><td align="center" rowspan="1" colspan="1">32.2&#x000b1;3.3</td><td align="center" rowspan="1" colspan="1">32.7&#x000b1;5.8</td><td colspan="2" align="center" rowspan="1">28.7&#x000b1;5.8</td><td align="center" rowspan="1" colspan="1">29.4&#x000b1;7.7</td><td align="center" rowspan="1" colspan="1">0.52</td><td align="center" rowspan="1" colspan="1">0.18</td><td align="center" rowspan="1" colspan="1">0.91</td></tr><tr><td align="left" rowspan="1" colspan="1">VO<sub>2</sub> at AT (mL)</td><td align="center" rowspan="1" colspan="1">1030&#x000b1;287</td><td align="center" rowspan="1" colspan="1">1248&#x000b1;388</td><td colspan="2" align="center" rowspan="1">1033&#x000b1;319</td><td align="center" rowspan="1" colspan="1">1090&#x000b1;225</td><td align="center" rowspan="1" colspan="1">0.041</td><td align="center" rowspan="1" colspan="1">0.54</td><td align="center" rowspan="1" colspan="1">0.22</td></tr><tr><td align="left" rowspan="1" colspan="1">Max. O<sub>2</sub>/HR (mL)</td><td align="center" rowspan="1" colspan="1">16.2&#x000b1;2.2</td><td align="center" rowspan="1" colspan="1">16.7&#x000b1;2.8</td><td colspan="2" align="center" rowspan="1">14.0&#x000b1;4.0</td><td align="center" rowspan="1" colspan="1">15.4&#x000b1;3.8</td><td align="center" rowspan="1" colspan="1">0.006</td><td align="center" rowspan="1" colspan="1">0.25</td><td align="center" rowspan="1" colspan="1">0.13</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t002fn001"><p>Data is presented as mean&#x000b1;SD. P-values refer to a 2-way repeated measures ANOVA between the two training groups. One subject in the CT-group did not reach VO<sub>2peak</sub>, and therefore only VE/VCO<sub>2</sub> slope and VO<sub>2</sub> at AT could be determined.</p></fn><fn id="t002fn002"><p>
<sup>#</sup> For statistical reasons, data was analyzed with three separate tests to determine <italic>time</italic>, <italic>group</italic> and <italic>time*group</italic> P-values.</p></fn></table-wrap-foot></table-wrap></sec><sec id="sec026"><title>Vascular function/structure</title><p>We found no significant changes in brachial and superficial femoral artery diameter, peak blood flow, and FMD (<xref rid="pone.0141256.t003" ref-type="table">Table 3</xref>). No change in endothelium-independent dilation of the brachial artery was observed after training for both groups (<xref rid="pone.0141256.t003" ref-type="table">Table 3</xref>). Furthermore, we found no significant impact of HIT or CT on carotid artery IMT or IMT-to-lumen ratio (<xref rid="pone.0141256.t003" ref-type="table">Table 3</xref>).</p><table-wrap id="pone.0141256.t003" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0141256.t003</object-id><label>Table 3</label><caption><title>Brachial (BA) and superficial femoral artery (SFA) endothelium-dependent vasodilation through flow-mediated dilation (FMD), peak diameter and endothelium-independent dilation (GTN), and common carotid artery (CCA) intima-media thickness (IMT).</title></caption><alternatives><graphic id="pone.0141256.t003g" xlink:href="pone.0141256.t003"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">CT (n = 10)</th><th align="center" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">HIT (n = 10)</th><th align="center" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">P-value</th><th align="center" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1"/></tr><tr><th align="left" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">
<italic>Pre</italic>
</th><th align="center" rowspan="1" colspan="1">
<italic>Post</italic>
</th><th align="center" rowspan="1" colspan="1">
<italic>Pre</italic>
</th><th align="center" rowspan="1" colspan="1">
<italic>Post</italic>
</th><th align="center" rowspan="1" colspan="1">
<italic>Time</italic>
</th><th align="center" rowspan="1" colspan="1">
<italic>Group</italic>
</th><th align="center" rowspan="1" colspan="1">
<italic>Time*Group</italic>
</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">BA diameter (mm)</td><td align="center" rowspan="1" colspan="1">4.5&#x000b1;0.5</td><td align="center" rowspan="1" colspan="1">4.5&#x000b1;0.5</td><td align="center" rowspan="1" colspan="1">4.4&#x000b1;0.9</td><td align="center" rowspan="1" colspan="1">4.4&#x000b1;0.8</td><td align="center" rowspan="1" colspan="1">0.83</td><td align="center" rowspan="1" colspan="1">0.68</td><td align="center" rowspan="1" colspan="1">0.86</td></tr><tr><td align="left" rowspan="1" colspan="1">BA FMD (%)</td><td align="center" rowspan="1" colspan="1">5.2&#x000b1;2.5</td><td align="center" rowspan="1" colspan="1">4.8&#x000b1;3.0</td><td align="center" rowspan="1" colspan="1">5.3&#x000b1;2.6</td><td align="center" rowspan="1" colspan="1">4.7&#x000b1;2.5</td><td align="center" rowspan="1" colspan="1">0.33</td><td align="center" rowspan="1" colspan="1">0.92</td><td align="center" rowspan="1" colspan="1">0.98</td></tr><tr><td align="left" rowspan="1" colspan="1">BA FMD (%, scaled)</td><td align="center" rowspan="1" colspan="1">5.3&#x000b1;2.5</td><td align="center" rowspan="1" colspan="1">4.8&#x000b1;2.5</td><td align="center" rowspan="1" colspan="1">5.2&#x000b1;2.5</td><td align="center" rowspan="1" colspan="1">4.6&#x000b1;2.5</td><td align="center" rowspan="1" colspan="1">0.47</td><td align="center" rowspan="1" colspan="1">&#x0003e;0.999</td><td align="center" rowspan="1" colspan="1">0.91<xref rid="t003fn002" ref-type="table-fn">
<sup>#</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">BA SR<sub>AUC</sub> (s, 10<sup>3</sup>)</td><td align="center" rowspan="1" colspan="1">19.9&#x000b1;9.6</td><td align="center" rowspan="1" colspan="1">18.6&#x000b1;7.4</td><td align="center" rowspan="1" colspan="1">17.8&#x000b1;9.2</td><td align="center" rowspan="1" colspan="1">22.3&#x000b1;7.7</td><td align="center" rowspan="1" colspan="1">0.42</td><td align="center" rowspan="1" colspan="1">0.80</td><td align="center" rowspan="1" colspan="1">0.14</td></tr><tr><td align="left" rowspan="1" colspan="1">BA GTN (%)</td><td align="center" rowspan="1" colspan="1">17.6&#x000b1;7.0</td><td align="center" rowspan="1" colspan="1">16.3&#x000b1;6.5</td><td align="center" rowspan="1" colspan="1">16.8&#x000b1;8.7</td><td align="center" rowspan="1" colspan="1">15.2&#x000b1;4.9</td><td align="center" rowspan="1" colspan="1">0.33</td><td align="center" rowspan="1" colspan="1">0.74</td><td align="center" rowspan="1" colspan="1">0.92</td></tr><tr><td align="left" rowspan="1" colspan="1">BA GTN (%, scaled)</td><td align="center" rowspan="1" colspan="1">17.9&#x000b1;4.5</td><td align="center" rowspan="1" colspan="1">16.6&#x000b1;4.5</td><td align="center" rowspan="1" colspan="1">16.1&#x000b1;4.5</td><td align="center" rowspan="1" colspan="1">14.6&#x000b1;4.5</td><td align="center" rowspan="1" colspan="1">0.42</td><td align="center" rowspan="1" colspan="1">0.27</td><td align="center" rowspan="1" colspan="1">0.94</td></tr><tr><td align="left" rowspan="1" colspan="1">BA FMD-GTN ratio</td><td align="center" rowspan="1" colspan="1">0.34&#x000b1;0.21</td><td align="center" rowspan="1" colspan="1">0.33&#x000b1;0.24</td><td align="center" rowspan="1" colspan="1">0.42&#x000b1;0.30</td><td align="center" rowspan="1" colspan="1">0.34&#x000b1;0.15</td><td align="center" rowspan="1" colspan="1">0.46</td><td align="center" rowspan="1" colspan="1">0.63</td><td align="center" rowspan="1" colspan="1">0.82</td></tr><tr><td align="left" rowspan="1" colspan="1">BA CADC (%)</td><td align="center" rowspan="1" colspan="1">10.6&#x000b1;6.4</td><td align="center" rowspan="1" colspan="1">11.3&#x000b1;4.8</td><td align="center" rowspan="1" colspan="1">16.1&#x000b1;7.4</td><td align="center" rowspan="1" colspan="1">13.4&#x000b1;5.5</td><td align="center" rowspan="1" colspan="1">0.52</td><td align="center" rowspan="1" colspan="1">0.12</td><td align="center" rowspan="1" colspan="1">0.26</td></tr><tr><td align="left" rowspan="1" colspan="1">BA CADC (%, scaled)</td><td align="center" rowspan="1" colspan="1">11.0&#x000b1;4.2</td><td align="center" rowspan="1" colspan="1">12.0&#x000b1;4.2</td><td align="center" rowspan="1" colspan="1">15.0&#x000b1;4.2</td><td align="center" rowspan="1" colspan="1">12.8&#x000b1;4.2</td><td align="center" rowspan="1" colspan="1">0.72</td><td align="center" rowspan="1" colspan="1">0.11</td><td align="center" rowspan="1" colspan="1">0.27</td></tr><tr><td align="left" rowspan="1" colspan="1">BA peak blood flow (mL/min)</td><td align="center" rowspan="1" colspan="1">794&#x000b1;139</td><td align="center" rowspan="1" colspan="1">862&#x000b1;261</td><td align="center" rowspan="1" colspan="1">711&#x000b1;264</td><td align="center" rowspan="1" colspan="1">556&#x000b1;165</td><td align="center" rowspan="1" colspan="1">0.38</td><td align="center" rowspan="1" colspan="1">0.56</td><td align="center" rowspan="1" colspan="1">0.46</td></tr><tr><td align="left" rowspan="1" colspan="1">SFA diameter (mm)</td><td align="center" rowspan="1" colspan="1">7.1&#x000b1;1.2</td><td align="center" rowspan="1" colspan="1">6.9&#x000b1;1.2</td><td align="center" rowspan="1" colspan="1">6.7&#x000b1;1.1</td><td align="center" rowspan="1" colspan="1">6.5&#x000b1;1.0</td><td align="center" rowspan="1" colspan="1">0.38</td><td align="center" rowspan="1" colspan="1">0.48</td><td align="center" rowspan="1" colspan="1">0.88</td></tr><tr><td align="left" rowspan="1" colspan="1">SFA FMD (%)</td><td align="center" rowspan="1" colspan="1">3.3&#x000b1;1.9</td><td align="center" rowspan="1" colspan="1">5.1&#x000b1;4.8</td><td align="center" rowspan="1" colspan="1">4.2&#x000b1;1.8</td><td align="center" rowspan="1" colspan="1">3.4&#x000b1;2.8</td><td align="center" rowspan="1" colspan="1">0.58</td><td align="center" rowspan="1" colspan="1">0.74</td><td align="center" rowspan="1" colspan="1">0.19</td></tr><tr><td align="left" rowspan="1" colspan="1">SFA FMD (%, scaled)</td><td align="center" rowspan="1" colspan="1">3.5&#x000b1;2.9</td><td align="center" rowspan="1" colspan="1">5.1&#x000b1;2.9</td><td align="center" rowspan="1" colspan="1">4.1&#x000b1;2.9</td><td align="center" rowspan="1" colspan="1">3.1&#x000b1;2.9</td><td align="center" rowspan="1" colspan="1">0.74</td><td align="center" rowspan="1" colspan="1">0.50</td><td align="center" rowspan="1" colspan="1">0.19</td></tr><tr><td align="left" rowspan="1" colspan="1">SFA SR<sub>AUC</sub> (s, 10<sup>3</sup>)</td><td align="center" rowspan="1" colspan="1">9.2&#x000b1;5.6</td><td align="center" rowspan="1" colspan="1">10.4&#x000b1;10.8</td><td align="center" rowspan="1" colspan="1">13.5&#x000b1;7.2</td><td align="center" rowspan="1" colspan="1">6.9&#x000b1;3.9</td><td align="center" rowspan="1" colspan="1">0.11</td><td align="center" rowspan="1" colspan="1">0.80</td><td align="center" rowspan="1" colspan="1">0.07</td></tr><tr><td align="left" rowspan="1" colspan="1">CA IMT (mm)</td><td align="center" rowspan="1" colspan="1">0.80&#x000b1;0.13</td><td align="center" rowspan="1" colspan="1">0.76&#x000b1;0.20</td><td align="center" rowspan="1" colspan="1">0.72&#x000b1;0.12</td><td align="center" rowspan="1" colspan="1">0.67&#x000b1;0.16</td><td align="center" rowspan="1" colspan="1">0.20</td><td align="center" rowspan="1" colspan="1">0.24</td><td align="center" rowspan="1" colspan="1">0.96</td></tr><tr><td align="left" rowspan="1" colspan="1">CA IMT-to-lumen ratio</td><td align="center" rowspan="1" colspan="1">0.12&#x000b1;0.02</td><td align="center" rowspan="1" colspan="1">0.11&#x000b1;0.02</td><td align="center" rowspan="1" colspan="1">0.11&#x000b1;0.02</td><td align="center" rowspan="1" colspan="1">0.11&#x000b1;0.02</td><td align="center" rowspan="1" colspan="1">0.40</td><td align="center" rowspan="1" colspan="1">0.59</td><td align="center" rowspan="1" colspan="1">0.45</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t003fn001"><p>Data is presented as mean&#x000b1;SD. P-values refer to 2-way repeated measures ANOVA between the 2 training groups.</p></fn><fn id="t003fn002"><p>
<sup>#</sup> For statistical reasons, data was analyzed with three separate tests to determine <italic>time</italic>, <italic>group</italic> and <italic>time*group</italic> P-values. Due to technical problems, BA GTN/FMD-GTN ratio/peak blood flow was available for 9 subjects in the HIT-group and SFA FMD was available for 8 subjects in the HIT-group. CCA IMT and IMT-to-lumen ratio were available for 8 subjects in each group. SR<sub>AUC</sub>; shear rate area-under-the-curve. CADC; conduit artery dilating capacity.</p></fn></table-wrap-foot></table-wrap></sec><sec id="sec027"><title>Cardiac function/structure</title><p>Most of the parameters of cardiac systolic function, left ventricle strain, or diastolic function demonstrated no change after HIT or CT (<xref rid="pone.0141256.t004" ref-type="table">Table 4</xref>). Negligible but significant changes were found in area strain and isovolumetric contraction time (<xref rid="pone.0141256.t004" ref-type="table">Table 4</xref>).</p><table-wrap id="pone.0141256.t004" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0141256.t004</object-id><label>Table 4</label><caption><title>Echocardiographic left ventricular volumes, systolic function, strain and diastolic function.</title></caption><alternatives><graphic id="pone.0141256.t004g" xlink:href="pone.0141256.t004"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">CT (n = 10)</th><th align="center" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">HIT (n = 10)</th><th align="center" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">P-value</th><th align="center" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1"/></tr><tr><th align="left" rowspan="1" colspan="1">Systolic function</th><th align="center" rowspan="1" colspan="1">
<italic>Pre</italic>
</th><th align="center" rowspan="1" colspan="1">
<italic>Post</italic>
</th><th align="center" rowspan="1" colspan="1">
<italic>Pre</italic>
</th><th align="center" rowspan="1" colspan="1">
<italic>Post</italic>
</th><th align="center" rowspan="1" colspan="1">
<italic>Time</italic>
</th><th align="center" rowspan="1" colspan="1">
<italic>Group</italic>
</th><th align="center" rowspan="1" colspan="1">
<italic>Time*Group</italic>
</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">LVEDV (ml)</td><td align="center" rowspan="1" colspan="1">154&#x000b1;24</td><td align="center" rowspan="1" colspan="1">159&#x000b1;28</td><td align="center" rowspan="1" colspan="1">194&#x000b1;39</td><td align="center" rowspan="1" colspan="1">204&#x000b1;44</td><td align="center" rowspan="1" colspan="1">0.26</td><td align="center" rowspan="1" colspan="1">0.002</td><td align="center" rowspan="1" colspan="1">0.64<xref rid="t004fn002" ref-type="table-fn">
<sup>#</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">LVESV (ml)</td><td align="center" rowspan="1" colspan="1">98&#x000b1;14</td><td align="center" rowspan="1" colspan="1">102&#x000b1;19</td><td align="center" rowspan="1" colspan="1">134&#x000b1;32</td><td align="center" rowspan="1" colspan="1">132&#x000b1;40</td><td align="center" rowspan="1" colspan="1">0.87</td><td align="center" rowspan="1" colspan="1">0.037</td><td align="center" rowspan="1" colspan="1">0.63</td></tr><tr><td align="left" rowspan="1" colspan="1">Stroke volume (ml)</td><td align="center" rowspan="1" colspan="1">56&#x000b1;13</td><td align="center" rowspan="1" colspan="1">57&#x000b1;13</td><td align="center" rowspan="1" colspan="1">61&#x000b1;14</td><td align="center" rowspan="1" colspan="1">72&#x000b1;16</td><td align="center" rowspan="1" colspan="1">0.06</td><td align="center" rowspan="1" colspan="1">0.16</td><td align="center" rowspan="1" colspan="1">0.12</td></tr><tr><td align="left" rowspan="1" colspan="1">LVEF (%)</td><td align="center" rowspan="1" colspan="1">36&#x000b1;4</td><td align="center" rowspan="1" colspan="1">36&#x000b1;5</td><td align="center" rowspan="1" colspan="1">32&#x000b1;7</td><td align="center" rowspan="1" colspan="1">36&#x000b1;9</td><td align="center" rowspan="1" colspan="1">0.09</td><td align="center" rowspan="1" colspan="1">0.57</td><td align="center" rowspan="1" colspan="1">0.07</td></tr><tr><td align="left" rowspan="1" colspan="1">Cardiac output (L/min)</td><td align="center" rowspan="1" colspan="1">3.5&#x000b1;0.6</td><td align="center" rowspan="1" colspan="1">3.4&#x000b1;0.7</td><td align="center" rowspan="1" colspan="1">3.5&#x000b1;0.8</td><td align="center" rowspan="1" colspan="1">4.3&#x000b1;1.0</td><td align="center" rowspan="1" colspan="1">0.20</td><td align="center" rowspan="1" colspan="1">0.21</td><td align="center" rowspan="1" colspan="1">0.07</td></tr><tr><td align="left" rowspan="1" colspan="1">Cardiac index (L/min/m<sup>2</sup>)</td><td align="center" rowspan="1" colspan="1">1.7&#x000b1;0.3</td><td align="center" rowspan="1" colspan="1">1.6&#x000b1;0.3</td><td align="center" rowspan="1" colspan="1">1.7&#x000b1;0.4</td><td align="center" rowspan="1" colspan="1">2.1&#x000b1;0.5</td><td align="center" rowspan="1" colspan="1">0.22</td><td align="center" rowspan="1" colspan="1">0.14</td><td align="center" rowspan="1" colspan="1">0.08</td></tr><tr><td align="left" rowspan="1" colspan="1">Longitudinal strain (%)</td><td align="center" rowspan="1" colspan="1">-9&#x000b1;3</td><td align="center" rowspan="1" colspan="1">-9&#x000b1;3</td><td align="center" rowspan="1" colspan="1">-9&#x000b1;3</td><td align="center" rowspan="1" colspan="1">-8&#x000b1;3</td><td align="center" rowspan="1" colspan="1">0.60</td><td align="center" rowspan="1" colspan="1">0.47</td><td align="center" rowspan="1" colspan="1">0.38<xref rid="t004fn002" ref-type="table-fn">
<sup>#</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Circumferential strain (%)</td><td align="center" rowspan="1" colspan="1">-10&#x000b1;2</td><td align="center" rowspan="1" colspan="1">-10&#x000b1;3</td><td align="center" rowspan="1" colspan="1">-9&#x000b1;3</td><td align="center" rowspan="1" colspan="1">-8&#x000b1;3</td><td align="center" rowspan="1" colspan="1">0.22</td><td align="center" rowspan="1" colspan="1">0.43</td><td align="center" rowspan="1" colspan="1">0.19</td></tr><tr><td align="left" rowspan="1" colspan="1">Radial strain (%)</td><td align="center" rowspan="1" colspan="1">23&#x000b1;7</td><td align="center" rowspan="1" colspan="1">22&#x000b1;6</td><td align="center" rowspan="1" colspan="1">23&#x000b1;8</td><td align="center" rowspan="1" colspan="1">20&#x000b1;8</td><td align="center" rowspan="1" colspan="1">0.13</td><td align="center" rowspan="1" colspan="1">0.71</td><td align="center" rowspan="1" colspan="1">0.48</td></tr><tr><td align="left" rowspan="1" colspan="1">Area strain (%)</td><td align="center" rowspan="1" colspan="1">-17&#x000b1;4</td><td align="center" rowspan="1" colspan="1">-15&#x000b1;6</td><td align="center" rowspan="1" colspan="1">-17&#x000b1;5</td><td align="center" rowspan="1" colspan="1">-14&#x000b1;5</td><td align="center" rowspan="1" colspan="1">0.044</td><td align="center" rowspan="1" colspan="1">0.73</td><td align="center" rowspan="1" colspan="1">0.97</td></tr><tr><td align="left" rowspan="1" colspan="1">IVCT-L (ms)</td><td align="center" rowspan="1" colspan="1">52&#x000b1;7</td><td align="center" rowspan="1" colspan="1">50&#x000b1;10</td><td align="center" rowspan="1" colspan="1">49&#x000b1;12</td><td align="center" rowspan="1" colspan="1">58&#x000b1;7</td><td align="center" rowspan="1" colspan="1">0.18</td><td align="center" rowspan="1" colspan="1">0.56</td><td align="center" rowspan="1" colspan="1">0.029</td></tr><tr><td align="left" rowspan="1" colspan="1">IVCT-S (ms)</td><td align="center" rowspan="1" colspan="1">57&#x000b1;14</td><td align="center" rowspan="1" colspan="1">59&#x000b1;11</td><td align="center" rowspan="1" colspan="1">53&#x000b1;9</td><td align="center" rowspan="1" colspan="1">56&#x000b1;11</td><td align="center" rowspan="1" colspan="1">0.35</td><td align="center" rowspan="1" colspan="1">0.46</td><td align="center" rowspan="1" colspan="1">0.87</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Diastolic function</bold>
</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">IVRT-L (ms)</td><td align="center" rowspan="1" colspan="1">145&#x000b1;32</td><td align="center" rowspan="1" colspan="1">149&#x000b1;27</td><td align="center" rowspan="1" colspan="1">142&#x000b1;27</td><td align="center" rowspan="1" colspan="1">159&#x000b1;27</td><td align="center" rowspan="1" colspan="1">0.13</td><td align="center" rowspan="1" colspan="1">0.75</td><td align="center" rowspan="1" colspan="1">0.38</td></tr><tr><td align="left" rowspan="1" colspan="1">IVRT-S (ms)</td><td align="center" rowspan="1" colspan="1">160&#x000b1;36</td><td align="center" rowspan="1" colspan="1">148&#x000b1;22</td><td align="center" rowspan="1" colspan="1">164&#x000b1;41</td><td align="center" rowspan="1" colspan="1">170&#x000b1;37</td><td align="center" rowspan="1" colspan="1">0.60</td><td align="center" rowspan="1" colspan="1">0.45</td><td align="center" rowspan="1" colspan="1">0.22<xref rid="t004fn002" ref-type="table-fn">
<sup>#</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">E/A</td><td align="center" rowspan="1" colspan="1">1.15&#x000b1;0.71</td><td align="center" rowspan="1" colspan="1">1.17&#x000b1;0.89</td><td align="center" rowspan="1" colspan="1">1.53&#x000b1;1.42</td><td align="center" rowspan="1" colspan="1">1.60&#x000b1;1.53</td><td align="center" rowspan="1" colspan="1">0.49</td><td align="center" rowspan="1" colspan="1">0.36</td><td align="center" rowspan="1" colspan="1">0.59<xref rid="t004fn002" ref-type="table-fn">
<sup>#</sup>
</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">S/D</td><td align="center" rowspan="1" colspan="1">1.38&#x000b1;0.74</td><td align="center" rowspan="1" colspan="1">1.17&#x000b1;0.34</td><td align="center" rowspan="1" colspan="1">1.00&#x000b1;0.40</td><td align="center" rowspan="1" colspan="1">1.26&#x000b1;0.59</td><td align="center" rowspan="1" colspan="1">0.85</td><td align="center" rowspan="1" colspan="1">0.48</td><td align="center" rowspan="1" colspan="1">0.14</td></tr><tr><td align="left" rowspan="1" colspan="1">E/E&#x02019;-L</td><td align="center" rowspan="1" colspan="1">6.8&#x000b1;1.9</td><td align="center" rowspan="1" colspan="1">6.7&#x000b1;1.9</td><td align="center" rowspan="1" colspan="1">10.3&#x000b1;4.4</td><td align="center" rowspan="1" colspan="1">9.8&#x000b1;6.3</td><td align="center" rowspan="1" colspan="1">0.71</td><td align="center" rowspan="1" colspan="1">0.07</td><td align="center" rowspan="1" colspan="1">0.74</td></tr><tr><td align="left" rowspan="1" colspan="1">E/E&#x02019;-S</td><td align="center" rowspan="1" colspan="1">10.1&#x000b1;4.1</td><td align="center" rowspan="1" colspan="1">11.1&#x000b1;5.2</td><td align="center" rowspan="1" colspan="1">12.6&#x000b1;9.8</td><td align="center" rowspan="1" colspan="1">11.8&#x000b1;11.2</td><td align="center" rowspan="1" colspan="1">0.93</td><td align="center" rowspan="1" colspan="1">0.67</td><td align="center" rowspan="1" colspan="1">0.42</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t004fn001"><p>Data is presented as mean&#x000b1;SD. P-values refers to 2-way repeated measures ANOVA between the 2 training groups.</p></fn><fn id="t004fn002"><p>
<sup>#</sup> For statistical reasons, data was analyzed with three separate tests were performed to determine <italic>time</italic>, <italic>group</italic> and <italic>time*group</italic> P-values. 4D data was available for 7 patients in the CT-group and 8 patients in the HIT-group. IVCT-l, IVRT-C, IVRT-S and E/E&#x02019;-L was available for 9 patients in the HIT-group. IVCT-S and E/E&#x02019;-S was available for 8 patients in the HIT-group. IVCT-L and S/D ratio was available for 9 subjects in the CT-group. IVRT-L and E/A ratio was available for 8 subjects in the CT-group.</p></fn><fn id="t004fn003"><p>LVEDV; left ventricular end-diastolic volume. LVESV; left-ventricular end-systolic volume. IVCT-L/S: isovolumetric contraction time, lateral/septal. IVRT-L/S; isovolumetric relaxation time, lateral/septal. E/A ratio; peak mitral flow velocity during early filling/peak mitral flow velocity during atrial contraction. S/D; systolic flow velocity pulmonary vein/diastolic flow velocity pulmonary vein. E/E&#x02019;-L/S; peak mitral flow velocity during early filling/peak mitral annulus velocity during early filling, lateral/septal.</p></fn></table-wrap-foot></table-wrap></sec><sec id="sec028"><title>Quality of life</title><p>There was no significant change in the SF-36 total score (<xref rid="pone.0141256.t005" ref-type="table">Table 5</xref>). There was a significant increase in the SF-36 subscale 'physical function' after training (P = 0.004, <xref rid="pone.0141256.t005" ref-type="table">Table 5</xref>), which did not differ between groups (time*group P = 0.11). A trend for an inverse correlation was found between baseline SF-36 scores and training-induced change in SF-36 scores (r = -0.51, P = 0.052). We found no change in the MLHFQ for both groups (<xref rid="pone.0141256.t005" ref-type="table">Table 5</xref>). No significant correlations were found between baseline MLHFQ scores and training-induced change in MLHFQ.</p><table-wrap id="pone.0141256.t005" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0141256.t005</object-id><label>Table 5</label><caption><title>Results of the SF-36 and Minnesota living with HF questionnaire (MLHFQ).</title></caption><alternatives><graphic id="pone.0141256.t005g" xlink:href="pone.0141256.t005"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">CT (n = 9)</th><th align="center" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">HIT (n = 8)</th><th align="center" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">P-value</th><th align="center" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1"/></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">
<bold>SF-36</bold>
</td><td align="center" rowspan="1" colspan="1">
<italic>Pre</italic>
</td><td align="center" rowspan="1" colspan="1">
<italic>Post</italic>
</td><td align="center" rowspan="1" colspan="1">
<italic>Pre</italic>
</td><td align="center" rowspan="1" colspan="1">
<italic>Post</italic>
</td><td align="center" rowspan="1" colspan="1">
<italic>Time</italic>
</td><td align="center" rowspan="1" colspan="1">
<italic>Group</italic>
</td><td align="center" rowspan="1" colspan="1">
<italic>Time*Group</italic>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Physical functioning</td><td align="center" rowspan="1" colspan="1">74&#x000b1;22</td><td align="center" rowspan="1" colspan="1">78&#x000b1;17</td><td align="center" rowspan="1" colspan="1">57&#x000b1;21</td><td align="center" rowspan="1" colspan="1">69&#x000b1;17</td><td align="center" rowspan="1" colspan="1">0.004</td><td align="center" rowspan="1" colspan="1">0.16</td><td align="center" rowspan="1" colspan="1">0.11</td></tr><tr><td align="left" rowspan="1" colspan="1">Physical health subscore<xref rid="t005fn002" ref-type="table-fn">
<sup>&#x02020;</sup>
</xref>
</td><td align="center" rowspan="1" colspan="1">73&#x000b1;20</td><td align="center" rowspan="1" colspan="1">76&#x000b1;16</td><td align="center" rowspan="1" colspan="1">60&#x000b1;22</td><td align="center" rowspan="1" colspan="1">67&#x000b1;19</td><td align="center" rowspan="1" colspan="1">0.15</td><td align="center" rowspan="1" colspan="1">0.26</td><td align="center" rowspan="1" colspan="1">0.52</td></tr><tr><td align="left" rowspan="1" colspan="1">Mental health subscore<xref rid="t005fn002" ref-type="table-fn">
<sup>&#x02020;</sup>
</xref>
<sup>,</sup>
<xref rid="t005fn003" ref-type="table-fn">
<sup>&#x02021;</sup>
</xref>
</td><td align="center" rowspan="1" colspan="1">81&#x000b1;9</td><td align="center" rowspan="1" colspan="1">83&#x000b1;10</td><td align="center" rowspan="1" colspan="1">83&#x000b1;5</td><td align="center" rowspan="1" colspan="1">82&#x000b1;10</td><td align="center" rowspan="1" colspan="1">0.75</td><td align="center" rowspan="1" colspan="1">0.87</td><td align="center" rowspan="1" colspan="1">0.54</td></tr><tr><td align="left" rowspan="1" colspan="1">Total score<xref rid="t005fn002" ref-type="table-fn">
<sup>&#x02020;</sup>
</xref>
<sup>,</sup>
<xref rid="t005fn003" ref-type="table-fn">
<sup>&#x02021;</sup>
</xref>
</td><td align="center" rowspan="1" colspan="1">75&#x000b1;16</td><td align="center" rowspan="1" colspan="1">78&#x000b1;13</td><td align="center" rowspan="1" colspan="1">68&#x000b1;14</td><td align="center" rowspan="1" colspan="1">73&#x000b1;14</td><td align="center" rowspan="1" colspan="1">0.18</td><td align="center" rowspan="1" colspan="1">0.42</td><td align="center" rowspan="1" colspan="1">0.76</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">
<bold>CT (n = 9)</bold>
</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">
<bold>HIT (n = 10)</bold>
</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">
<bold>P-value</bold>
</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>MLHFQ</bold>
</td><td align="center" rowspan="1" colspan="1">
<italic>Pre</italic>
</td><td align="center" rowspan="1" colspan="1">
<italic>Post</italic>
</td><td align="center" rowspan="1" colspan="1">
<italic>Pre</italic>
</td><td align="center" rowspan="1" colspan="1">
<italic>Post</italic>
</td><td align="center" rowspan="1" colspan="1">
<italic>Time</italic>
</td><td align="center" rowspan="1" colspan="1">
<italic>Group</italic>
</td><td align="center" rowspan="1" colspan="1">
<italic>Time*Group</italic>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Total score</td><td align="center" rowspan="1" colspan="1">18&#x000b1;14</td><td align="center" rowspan="1" colspan="1">16&#x000b1;16</td><td align="center" rowspan="1" colspan="1">21&#x000b1;15</td><td align="center" rowspan="1" colspan="1">20&#x000b1;14</td><td align="center" rowspan="1" colspan="1">0.81</td><td align="center" rowspan="1" colspan="1">0.56</td><td align="center" rowspan="1" colspan="1">0.89</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t005fn001"><p>Data is presented as mean&#x000b1;SD. P-values refers to 2-way repeated measures ANOVA between the 2 training groups. Results of the SF-36 were scored on a 0&#x02013;100 scale, in which a high score represents a better quality of life. Results of the MLHFQ were scored on a 0&#x02013;105 scale, in which a low score indicates few HF-related complaints.</p></fn><fn id="t005fn002"><p>
<sup>&#x02020;</sup> Data was available for 7 subjects in the HIT-group.</p></fn><fn id="t005fn003"><p>
<sup>&#x02021;</sup> Data was available for 8 subjects in the CT-group.</p></fn></table-wrap-foot></table-wrap></sec><sec id="sec029"><title>Control group</title><p>We found no changes over the 12-week period in maximal oxygen uptake (17.4&#x000b1;5.9 <italic>versus</italic> 17.5&#x000b1;5.8 ml/min/kg, P = 0.79) or in any of the other parameters of physical fitness (all P&#x0003e;0.05, <xref rid="pone.0141256.s003" ref-type="supplementary-material">S1 Table</xref>). Except for a decrease across time in the superficial femoral artery FMD and an increase in lateral E-E&#x02019;-ratio, we found no changes in cardiac and vascular structure or function or in the SF-36 score and MLHFQ in controls (all P&#x0003e;0.05, <xref rid="pone.0141256.s003" ref-type="supplementary-material">S1 Table</xref>).</p></sec></sec></sec><sec sec-type="conclusions" id="sec030"><title>Discussion</title><p>This study comprehensively compared physical fitness, vascular function, cardiac function and quality of life between a feasible and practical HIT-protocol <italic>versus</italic> traditional CT in HF patients. We have demonstrated that CT and HIT are both feasible in HF patients and induced a significant improvement in measures of (sub)maximal exercise performance and fitness, with no significant differences between both types of exercise training. Despite these changes in fitness, we did not find improvement in measures of resting cardiac and vascular structure and function. Furthermore, except an improvement in the subscale &#x02018;physical function&#x02019; that may be related to the change in fitness, no effect of training was found on quality of life. Therefore, our data suggest that both types of exercise training successfully improve measures of physical fitness within 12-weeks, but not cardiovascular function at rest or quality of life. Moreover, we found no evidence for superiority of this more feasible HIT-protocol over traditional CT on the parameters presented in our study.</p><sec id="sec031"><title>Physical fitness</title><p>Previous work found improvements in physical fitness in HF after HIT ranging from 8&#x02013;46% [<xref rid="pone.0141256.ref016" ref-type="bibr">16</xref>,<xref rid="pone.0141256.ref020" ref-type="bibr">20</xref>,<xref rid="pone.0141256.ref021" ref-type="bibr">21</xref>], whilst studies adopting CT found changes ranging between 0&#x02013;22% [<xref rid="pone.0141256.ref017" ref-type="bibr">17</xref>,<xref rid="pone.0141256.ref019" ref-type="bibr">19</xref>]. Most of these training studies have included low numbers of participants, which may explain the large variation in results. The largest HF exercise training study so far (&#x0003e;1,000 participants), the HF-ACTION trial, reported a median increase in fitness of 4% [<xref rid="pone.0141256.ref039" ref-type="bibr">39</xref>]. Although in the lower ends of the spectrum, the change in physical fitness in our study (~4%) is within the range of improvements as reported in previous work. As demonstrated in various previous studies, training characteristics (e.g. frequency, intensity and duration) are important factors determining training responses [<xref rid="pone.0141256.ref040" ref-type="bibr">40</xref>]. Nonetheless, our relatively low-frequency protocols were sufficient to induce significant improvements in fitness levels. Similar observations were made by Belardinelli <italic>et al</italic> [<xref rid="pone.0141256.ref023" ref-type="bibr">23</xref>], who adopted a long-term (10-year), low-frequency exercise training program in HF patients. They reported improvement in physical fitness levels in trained subjects after 1 year of training, whilst fitness levels remained higher than in controls across the 10-year intervention. In addition to the low frequency of training, the relatively modest changes in fitness in our study may relate to characteristics of the included participants, such as genetic factors [<xref rid="pone.0141256.ref041" ref-type="bibr">41</xref>] or to <italic>a priori</italic> higher levels of physical fitness as lower physical fitness levels are associated with larger training-induced improvements in HF patients [<xref rid="pone.0141256.ref042" ref-type="bibr">42</xref>,<xref rid="pone.0141256.ref043" ref-type="bibr">43</xref>]. Indeed, some previous HIT-studies demonstrated large improvement after exercise training in HF patients with low baseline levels of physical fitness [<xref rid="pone.0141256.ref016" ref-type="bibr">16</xref>&#x02013;<xref rid="pone.0141256.ref018" ref-type="bibr">18</xref>]. Moreover, patients with chronotropic incompetence (i.e. 68% in our study) have attenuated exercise-induced improvement in parameters of fitness, which could have affected the effect size in our study [<xref rid="pone.0141256.ref044" ref-type="bibr">44</xref>]. Despite the relatively modest effect sizes, our exercise training protocols were successful in improving parameters of physical fitness.</p><p>We did not demonstrate significant differences between CT and HIT on the change in physical fitness, a finding which is in agreement with some [<xref rid="pone.0141256.ref018" ref-type="bibr">18</xref>,<xref rid="pone.0141256.ref019" ref-type="bibr">19</xref>,<xref rid="pone.0141256.ref022" ref-type="bibr">22</xref>], but not all previous studies [<xref rid="pone.0141256.ref016" ref-type="bibr">16</xref>,<xref rid="pone.0141256.ref017" ref-type="bibr">17</xref>]. Interestingly, recent meta-analyses suggest that (high-intensity) interval training results in superior effects on physical fitness compared to CT in HF [<xref rid="pone.0141256.ref045" ref-type="bibr">45</xref>,<xref rid="pone.0141256.ref046" ref-type="bibr">46</xref>]. Despite these promising results of HIT in HF, larger trials that focus on clinical end-points are needed [<xref rid="pone.0141256.ref047" ref-type="bibr">47</xref>]. Also, limitations of a meta-analysis should be taken into consideration, as both HIT and CT interventions included in these meta-analyses comprise of many different protocols and exercise intensities. Especially for HIT, it is suggested that the time spent at a high percentage of peak oxygen uptake, determined by intensity and duration of the work and rest intervals, importantly contributes to the effect size [<xref rid="pone.0141256.ref048" ref-type="bibr">48</xref>]. Whilst the intensity of our high-intensity-bouts is high, the time spent at these high-intensity bouts was lower than in previous studies demonstrating superior effects of HIT compared to CT [<xref rid="pone.0141256.ref016" ref-type="bibr">16</xref>,<xref rid="pone.0141256.ref017" ref-type="bibr">17</xref>]. Furthermore, to validly compare exercise training regimes, it is important that total workload is not significantly different. A study that compared training-effects of HIT and CT and applied individually designed training programs with specific emphasis on comparable workloads for HIT and CT, found no differences between training modalities [<xref rid="pone.0141256.ref019" ref-type="bibr">19</xref>]. Therefore, more rigorous exercise programs (both in frequency, duration, and training load) rather than the type of training <italic>per se</italic> may contribute to larger improvements in physical fitness.</p></sec><sec id="sec032"><title>Cardiac and vascular adaptation</title><p>Exercise in HF patients is associated with beneficial cardiac remodelling [<xref rid="pone.0141256.ref008" ref-type="bibr">8</xref>]. After 12-weeks of training, we found no improvements in cardiac structure and function at rest, although the increase in maximal oxygen pulse suggests an increase in stroke volume during exercise. Previous studies that reported significant changes in cardiac function or structure generally applied training periods &#x02265;6 months [<xref rid="pone.0141256.ref008" ref-type="bibr">8</xref>]. Therefore, the relatively short duration of training may contribute, at least partly, to the lack of cardiac remodelling in our study. Moreover, the largest proportion of our training-participants reported ischemic HF etiology. This could be of special importance, since a recent study suggested that cardiac adaptation during outpatient rehabilitation is more prominent in HF patients with non-ischemic etiology [<xref rid="pone.0141256.ref049" ref-type="bibr">49</xref>]. Furthermore, our results are in line with a recent meta-analysis that could not confirm that HIT is superior to CT to induce cardiac adaptations [<xref rid="pone.0141256.ref046" ref-type="bibr">46</xref>].</p><p>In our study, we found no superior effect of HIT to improve vascular function, which contrasts with the findings of a recent meta-analysis [<xref rid="pone.0141256.ref050" ref-type="bibr">50</xref>]. However, 4 out the 7 studies included in this meta-analysis showed a superior effect of HIT. Interestingly, these studies were all from the same laboratory and did not follow contemporary guidelines to assess endothelial function. We found no overall effect of exercise training on vascular function. As previous literature has reported a wide range of exercise-induced responses (and also demonstrated non-responders) in vascular function, Green <italic>et al</italic>. investigated which factors predict this response [<xref rid="pone.0141256.ref051" ref-type="bibr">51</xref>]. They concluded that exercise-induced improvements in vascular function are associated with a lower pre-training vascular function. When comparing the baseline FMD values of our subjects to normal values published previously [<xref rid="pone.0141256.ref052" ref-type="bibr">52</xref>], the endothelial function of the subjects in our study was within the normal range for their age. This may relate to the optimal pharmacological therapy of the HF patients we included [<xref rid="pone.0141256.ref053" ref-type="bibr">53</xref>]. Moreover, we have previously demonstrated that the shear rate pattern during exercise (i.e. an important stimulus for exercise-induced adaptation in vascular function) is less beneficial in HF patients compared to controls [<xref rid="pone.0141256.ref054" ref-type="bibr">54</xref>]. Preserved FMD before training and a suboptimal shear rate stimulus during exercise training may contribute to the absence of a significant training-induced change in vascular function.</p></sec><sec id="sec033"><title>Quality of life</title><p>Quality of life after exercise training in HF patients is previously demonstrated to improve [<xref rid="pone.0141256.ref007" ref-type="bibr">7</xref>,<xref rid="pone.0141256.ref055" ref-type="bibr">55</xref>]. In our study, we indeed found improvement in the subscale for physical functioning after exercise training, but not for total quality of life. The lack of improvement in quality of life may relate to the relatively &#x02018;good&#x02019; quality of life at baseline, which was well above that of previous studies [<xref rid="pone.0141256.ref017" ref-type="bibr">17</xref>,<xref rid="pone.0141256.ref056" ref-type="bibr">56</xref>,<xref rid="pone.0141256.ref057" ref-type="bibr">57</xref>] and consequently, provides little space for further improvement. In support of this idea, we observed a trend for an inverse relation between baseline SF-36 and change in SF-36 in the training group. This indicates that subjects with lower quality of life prior to exercise training demonstrate a larger benefit from the intervention. Furthermore, the inclusion of more relatively old HF patients in our study may also contribute to the smaller effect size of exercise training on quality of life, as demonstrated in a previous study [<xref rid="pone.0141256.ref058" ref-type="bibr">58</xref>]. This latter study found that older HF patients (&#x0003e;60 yrs) demonstrate a smaller effect of exercise training on quality of life compared to younger HF patients (&#x0003c;60 yrs).</p></sec><sec id="sec034"><title>Clinical relevance</title><p>Given the importance of (even small improvements in) fitness levels for the prognosis of HF patients [<xref rid="pone.0141256.ref005" ref-type="bibr">5</xref>,<xref rid="pone.0141256.ref006" ref-type="bibr">6</xref>,<xref rid="pone.0141256.ref059" ref-type="bibr">59</xref>], finding both a feasible and effective training program is clinically relevant. Another important factor is adherence to exercise training, which often is reported to be low in HF patients due to time-constraints and lack of energy [<xref rid="pone.0141256.ref060" ref-type="bibr">60</xref>]. A HIT training program with lower training frequency and high-intensity intervals of moderate duration might address these two major factors of non-compliance. Therefore, we have studied whether such a program is effective and whether it is superior to CT. The results of this study suggest that low frequency HIT with high-intensity intervals of moderate duration is feasible and successful in improving fitness. Such findings may be of clinical relevance and future studies should therefore focus on finding the optimal exercise protocol for HF patients to achieve long-term benefits and adherence.</p></sec><sec id="sec035"><title>Limitations</title><p>Although we have included a relatively small number of patients, our sample size was in line with previous studies that demonstrated differences in effects of HIT and CT on physical fitness [<xref rid="pone.0141256.ref016" ref-type="bibr">16</xref>,<xref rid="pone.0141256.ref017" ref-type="bibr">17</xref>] and vascular function [<xref rid="pone.0141256.ref050" ref-type="bibr">50</xref>]. Moreover, we have used state-of-the-art techniques for measuring physical fitness and vascular function, in contrast to some previous studies that used suboptimal techniques to assess endothelial function. Therefore, we <italic>a priori</italic> expected to have sufficient power to detect significant differences between HIT and CT. Post-hoc power analysis revealed a power of 54% to detect differences in change in physical fitness between the two types of training. Finally, we did not provide a comparison between HIT with short high-intensity bouts and HIT with long high-intensity bouts. We encourage future studies to investigate whether different HIT-protocols render different results and to elucidate the optimal HIT-protocol.</p><p>In conclusion, we have demonstrated that 12-weeks of exercise training in HF patients is associated with improvements in parameters of physical fitness, whilst no improvements in cardiovascular function at rest or (total) quality of life are observed. Moreover, our data does not provide strong evidence for a potentially superior improvement in physical fitness, cardiovascular function or quality of life after 12-weeks of HIT compared to CT in HF patients NYHA class II-III.</p></sec></sec><sec sec-type="supplementary-material" id="sec036"><title>Supporting Information</title><supplementary-material content-type="local-data" id="pone.0141256.s001"><label>S1 TREND Checklist</label><caption><title>TREND statement checklist.</title><p>(PDF)</p></caption><media xlink:href="pone.0141256.s001.pdf"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0141256.s002"><label>S1 Protocol</label><caption><title>Research protocol.</title><p>(PDF)</p></caption><media xlink:href="pone.0141256.s002.pdf"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0141256.s003"><label>S1 Table</label><caption><title>Results of the control group.</title><p>Data is presented as mean &#x000b1;SD. <sup>&#x02020;</sup>Data missing for 1 control subject. VO<sub>2peak</sub>; peak oxygen uptake. AT; anaerobic threshold. BA; brachial artery. SFA; superficial femoral artery. GTN; glyceryl trinitrate. CADC; conduit artery dilating capacity. IMT; intima-media thickness. SR<sub>AUC</sub>; shear rate area-under-the-curve. CADC; conduit artery dilating capacity. LVEDV; left ventricular end-diastolic volume. LVESV; left-ventricular end-systolic volume. IVCT-L/S: isovolumetric contraction time, lateral/septal. IVRT-L/S; isovolumetric relaxation time, lateral/septal. E/A ratio; peak mitral flow velocity during early filling/peak mitral flow velocity during atrial contraction. S/D; systolic flow velocity pulmonary vein/diastolic flow velocity pulmonary vein. E/E&#x02019;-L/S; peak mitral flow velocity during early filling/peak mitral annulus velocity during early filling, lateral/septal. MLHFQ; Minnesota living with heart failure questionnaire.</p><p>(DOCX)</p></caption><media xlink:href="pone.0141256.s003.docx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ack><p>We would like to thank Lisette Baltussen, Kim van Zutphen, Gini van Til, Ineke Cillessen, Ilse Bosman, and Jacqueline Kloek for their help with the recruitment of patients. We thank Shanna Bloemen, Rosa Holtslag, Sigrid Goossens, Maartje Glaap, Djerr Venderink and Caroline Langen for supervising the exercise training, and Kim Cortenbach for assisting with the data analysis.</p></ack><ref-list><title>References</title><ref id="pone.0141256.ref001"><label>1</label><mixed-citation publication-type="journal">
<name><surname>McCullough</surname><given-names>PA</given-names></name>, <name><surname>Philbin</surname><given-names>EF</given-names></name>, <name><surname>Spertus</surname><given-names>JA</given-names></name>, <name><surname>Kaatz</surname><given-names>S</given-names></name>, <name><surname>Sandberg</surname><given-names>KR</given-names></name>, <name><surname>Weaver</surname><given-names>WD</given-names></name>, <etal>et al</etal> (<year>2002</year>) <article-title>Confirmation of a heart failure epidemic: findings from the Resource Utilization Among Congestive Heart Failure (REACH) study</article-title>. <source>J Am Coll Cardiol</source>
<volume>39</volume>: <fpage>60</fpage>&#x02013;<lpage>69</lpage>.
<pub-id pub-id-type="pmid">11755288</pub-id></mixed-citation></ref><ref id="pone.0141256.ref002"><label>2</label><mixed-citation publication-type="journal">
<name><surname>Bleumink</surname><given-names>GS</given-names></name>, <name><surname>Knetsch</surname><given-names>AM</given-names></name>, <name><surname>Sturkenboom</surname><given-names>MC</given-names></name>, <name><surname>Straus</surname><given-names>SM</given-names></name>, <name><surname>Hofman</surname><given-names>A</given-names></name>, <name><surname>Deckers</surname><given-names>JW</given-names></name>, <etal>et al</etal> (<year>2004</year>) <article-title>Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure The Rotterdam Study</article-title>. <source>Eur Heart J</source>
<volume>25</volume>: <fpage>1614</fpage>&#x02013;<lpage>1619</lpage>.
<pub-id pub-id-type="pmid">15351160</pub-id></mixed-citation></ref><ref id="pone.0141256.ref003"><label>3</label><mixed-citation publication-type="journal">
<name><surname>Levy</surname><given-names>D</given-names></name>, <name><surname>Kenchaiah</surname><given-names>S</given-names></name>, <name><surname>Larson</surname><given-names>MG</given-names></name>, <name><surname>Benjamin</surname><given-names>EJ</given-names></name>, <name><surname>Kupka</surname><given-names>MJ</given-names></name>, <name><surname>Ho</surname><given-names>KK</given-names></name>, <etal>et al</etal> (<year>2002</year>) <article-title>Long-term trends in the incidence of and survival with heart failure</article-title>. <source>N Engl J Med</source>
<volume>347</volume>: <fpage>1397</fpage>&#x02013;<lpage>1402</lpage>.
<pub-id pub-id-type="pmid">12409541</pub-id></mixed-citation></ref><ref id="pone.0141256.ref004"><label>4</label><mixed-citation publication-type="journal">
<name><surname>Zarrinkoub</surname><given-names>R</given-names></name>, <name><surname>Wettermark</surname><given-names>B</given-names></name>, <name><surname>Wandell</surname><given-names>P</given-names></name>, <name><surname>Mejhert</surname><given-names>M</given-names></name>, <name><surname>Szulkin</surname><given-names>R</given-names></name>, <name><surname>Ljunggren</surname><given-names>G</given-names></name>, <etal>et al</etal> (<year>2013</year>) <article-title>The epidemiology of heart failure, based on data for 2.1 million inhabitants in Sweden</article-title>. <source>Eur J Heart Fail</source>
<volume>15</volume>: <fpage>995</fpage>&#x02013;<lpage>1002</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1093/eurjhf/hft064">10.1093/eurjhf/hft064</ext-link></comment>
<pub-id pub-id-type="pmid">23645498</pub-id></mixed-citation></ref><ref id="pone.0141256.ref005"><label>5</label><mixed-citation publication-type="journal">
<name><surname>Cahalin</surname><given-names>LP</given-names></name>, <name><surname>Chase</surname><given-names>P</given-names></name>, <name><surname>Arena</surname><given-names>R</given-names></name>, <name><surname>Myers</surname><given-names>J</given-names></name>, <name><surname>Bensimhon</surname><given-names>D</given-names></name>, <name><surname>Peberdy</surname><given-names>MA</given-names></name>, <etal>et al</etal> (<year>2013</year>) <article-title>A meta-analysis of the prognostic significance of cardiopulmonary exercise testing in patients with heart failure</article-title>. <source>Heart Fail Rev</source>
<volume>18</volume>: <fpage>79</fpage>&#x02013;<lpage>94</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/s10741-012-9332-0">10.1007/s10741-012-9332-0</ext-link></comment>
<pub-id pub-id-type="pmid">22733204</pub-id></mixed-citation></ref><ref id="pone.0141256.ref006"><label>6</label><mixed-citation publication-type="journal">
<name><surname>Myers</surname><given-names>J</given-names></name>, <name><surname>Gullestad</surname><given-names>L</given-names></name>, <name><surname>Vagelos</surname><given-names>R</given-names></name>, <name><surname>Do</surname><given-names>D</given-names></name>, <name><surname>Bellin</surname><given-names>D</given-names></name>, <name><surname>Ross</surname><given-names>H</given-names></name>, <etal>et al</etal> (<year>1998</year>) <article-title>Clinical, hemodynamic, and cardiopulmonary exercise test determinants of survival in patients referred for evaluation of heart failure</article-title>. <source>Ann Intern Med</source>
<volume>129</volume>: <fpage>286</fpage>&#x02013;<lpage>293</lpage>.
<pub-id pub-id-type="pmid">9729181</pub-id></mixed-citation></ref><ref id="pone.0141256.ref007"><label>7</label><mixed-citation publication-type="journal">
<name><surname>van Tol</surname><given-names>BA</given-names></name>, <name><surname>Huijsmans</surname><given-names>RJ</given-names></name>, <name><surname>Kroon</surname><given-names>DW</given-names></name>, <name><surname>Schothorst</surname><given-names>M</given-names></name>, <name><surname>Kwakkel</surname><given-names>G</given-names></name> (<year>2006</year>) <article-title>Effects of exercise training on cardiac performance, exercise capacity and quality of life in patients with heart failure: a meta-analysis</article-title>. <source>Eur J Heart Fail</source>
<volume>8</volume>: <fpage>841</fpage>&#x02013;<lpage>850</lpage>.
<pub-id pub-id-type="pmid">16713337</pub-id></mixed-citation></ref><ref id="pone.0141256.ref008"><label>8</label><mixed-citation publication-type="journal">
<name><surname>Haykowsky</surname><given-names>MJ</given-names></name>, <name><surname>Liang</surname><given-names>Y</given-names></name>, <name><surname>Pechter</surname><given-names>D</given-names></name>, <name><surname>Jones</surname><given-names>LW</given-names></name>, <name><surname>McAlister</surname><given-names>FA</given-names></name>, <name><surname>Clark</surname><given-names>AM</given-names></name> (<year>2007</year>) <article-title>A meta-analysis of the effect of exercise training on left ventricular remodeling in heart failure patients: the benefit depends on the type of training performed</article-title>. <source>J Am Coll Cardiol</source>
<volume>49</volume>: <fpage>2329</fpage>&#x02013;<lpage>2336</lpage>.
<pub-id pub-id-type="pmid">17572248</pub-id></mixed-citation></ref><ref id="pone.0141256.ref009"><label>9</label><mixed-citation publication-type="journal">
<name><surname>Hambrecht</surname><given-names>R</given-names></name>, <name><surname>Hilbrich</surname><given-names>L</given-names></name>, <name><surname>Erbs</surname><given-names>S</given-names></name>, <name><surname>Gielen</surname><given-names>S</given-names></name>, <name><surname>Fiehn</surname><given-names>E</given-names></name>, <name><surname>Schoene</surname><given-names>N</given-names></name>, <etal>et al</etal> (<year>2000</year>) <article-title>Correction of endothelial dysfunction in chronic heart failure: additional effects of exercise training and oral L-arginine supplementation</article-title>. <source>J Am Coll Cardiol</source>
<volume>35</volume>: <fpage>706</fpage>&#x02013;<lpage>713</lpage>.
<pub-id pub-id-type="pmid">10716474</pub-id></mixed-citation></ref><ref id="pone.0141256.ref010"><label>10</label><mixed-citation publication-type="journal">
<name><surname>Linke</surname><given-names>A</given-names></name>, <name><surname>Schoene</surname><given-names>N</given-names></name>, <name><surname>Gielen</surname><given-names>S</given-names></name>, <name><surname>Hofer</surname><given-names>J</given-names></name>, <name><surname>Erbs</surname><given-names>S</given-names></name>, <name><surname>Schuler</surname><given-names>G</given-names></name>, <etal>et al</etal> (<year>2001</year>) <article-title>Endothelial dysfunction in patients with chronic heart failure: systemic effects of lower-limb exercise training</article-title>. <source>J Am Coll Cardiol</source>
<volume>37</volume>: <fpage>392</fpage>&#x02013;<lpage>397</lpage>.
<pub-id pub-id-type="pmid">11216952</pub-id></mixed-citation></ref><ref id="pone.0141256.ref011"><label>11</label><mixed-citation publication-type="journal">
<name><surname>Lavie</surname><given-names>CJ</given-names></name>, <name><surname>Arena</surname><given-names>R</given-names></name>, <name><surname>Swift</surname><given-names>DL</given-names></name>, <name><surname>Johannsen</surname><given-names>NM</given-names></name>, <name><surname>Sui</surname><given-names>X</given-names></name>, <name><surname>Lee</surname><given-names>DC</given-names></name>, <etal>et al</etal> (<year>2015</year>) <article-title>Exercise and the Cardiovascular System: Clinical Science and Cardiovascular Outcomes</article-title>. <source>Circ Res</source>
<volume>117</volume>: <fpage>207</fpage>&#x02013;<lpage>219</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1161/CIRCRESAHA.117.305205">10.1161/CIRCRESAHA.117.305205</ext-link></comment>
<pub-id pub-id-type="pmid">26139859</pub-id></mixed-citation></ref><ref id="pone.0141256.ref012"><label>12</label><mixed-citation publication-type="journal">
<name><surname>Piepoli</surname><given-names>MF</given-names></name>, <name><surname>Conraads</surname><given-names>V</given-names></name>, <name><surname>Corra</surname><given-names>U</given-names></name>, <name><surname>Dickstein</surname><given-names>K</given-names></name>, <name><surname>Francis</surname><given-names>DP</given-names></name>, <name><surname>Jaarsma</surname><given-names>T</given-names></name>, <etal>et al</etal> (<year>2011</year>) <article-title>Exercise training in heart failure: from theory to practice. A consensus document of the Heart Failure Association and the European Association for Cardiovascular Prevention and Rehabilitation</article-title>. <source>Eur J Heart Fail</source>
<volume>13</volume>: <fpage>347</fpage>&#x02013;<lpage>357</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1093/eurjhf/hfr017">10.1093/eurjhf/hfr017</ext-link></comment>
<pub-id pub-id-type="pmid">21436360</pub-id></mixed-citation></ref><ref id="pone.0141256.ref013"><label>13</label><mixed-citation publication-type="journal">
<name><surname>Arena</surname><given-names>R</given-names></name>, <name><surname>Myers</surname><given-names>J</given-names></name>, <name><surname>Forman</surname><given-names>DE</given-names></name>, <name><surname>Lavie</surname><given-names>CJ</given-names></name>, <name><surname>Guazzi</surname><given-names>M</given-names></name> (<year>2013</year>) <article-title>Should high-intensity-aerobic interval training become the clinical standard in heart failure?</article-title>
<source>Heart Fail Rev</source>
<volume>18</volume>: <fpage>95</fpage>&#x02013;<lpage>105</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/s10741-012-9333-z">10.1007/s10741-012-9333-z</ext-link></comment>
<pub-id pub-id-type="pmid">22791516</pub-id></mixed-citation></ref><ref id="pone.0141256.ref014"><label>14</label><mixed-citation publication-type="journal">
<name><surname>Ismail</surname><given-names>H</given-names></name>, <name><surname>McFarlane</surname><given-names>JR</given-names></name>, <name><surname>Nojoumian</surname><given-names>AH</given-names></name>, <name><surname>Dieberg</surname><given-names>G</given-names></name>, <name><surname>Smart</surname><given-names>NA</given-names></name> (<year>2013</year>) <article-title>Clinical outcomes and cardiovascular responses to different exercise training intensities in patients with heart failure: a systematic review and meta-analysis</article-title>. <source>JACC Heart Fail</source>
<volume>1</volume>: <fpage>514</fpage>&#x02013;<lpage>522</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.jchf.2013.08.006">10.1016/j.jchf.2013.08.006</ext-link></comment>
<pub-id pub-id-type="pmid">24622004</pub-id></mixed-citation></ref><ref id="pone.0141256.ref015"><label>15</label><mixed-citation publication-type="journal">
<name><surname>Norton</surname><given-names>K</given-names></name>, <name><surname>Norton</surname><given-names>L</given-names></name>, <name><surname>Sadgrove</surname><given-names>D</given-names></name> (<year>2010</year>) <article-title>Position statement on physical activity and exercise intensity terminology</article-title>. <source>J Sci Med Sport</source>
<volume>13</volume>: <fpage>496</fpage>&#x02013;<lpage>502</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.jsams.2009.09.008">10.1016/j.jsams.2009.09.008</ext-link></comment>
<pub-id pub-id-type="pmid">20005170</pub-id></mixed-citation></ref><ref id="pone.0141256.ref016"><label>16</label><mixed-citation publication-type="journal">
<name><surname>Wisloff</surname><given-names>U</given-names></name>, <name><surname>Stoylen</surname><given-names>A</given-names></name>, <name><surname>Loennechen</surname><given-names>JP</given-names></name>, <name><surname>Bruvold</surname><given-names>M</given-names></name>, <name><surname>Rognmo</surname><given-names>O</given-names></name>, <name><surname>Haram</surname><given-names>PM</given-names></name>, <etal>et al</etal> (<year>2007</year>) <article-title>Superior cardiovascular effect of aerobic interval training versus moderate continuous training in heart failure patients: a randomized study</article-title>. <source>Circulation</source>
<volume>115</volume>: <fpage>3086</fpage>&#x02013;<lpage>3094</lpage>.
<pub-id pub-id-type="pmid">17548726</pub-id></mixed-citation></ref><ref id="pone.0141256.ref017"><label>17</label><mixed-citation publication-type="journal">
<name><surname>Fu</surname><given-names>TC</given-names></name>, <name><surname>Wang</surname><given-names>CH</given-names></name>, <name><surname>Lin</surname><given-names>PS</given-names></name>, <name><surname>Hsu</surname><given-names>CC</given-names></name>, <name><surname>Cherng</surname><given-names>WJ</given-names></name>, <name><surname>Huang</surname><given-names>SC</given-names></name>, <etal>et al</etal> (<year>2013</year>) <article-title>Aerobic interval training improves oxygen uptake efficiency by enhancing cerebral and muscular hemodynamics in patients with heart failure</article-title>. <source>Int J Cardiol</source>
<volume>167</volume>: <fpage>41</fpage>&#x02013;<lpage>50</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.ijcard.2011.11.086">10.1016/j.ijcard.2011.11.086</ext-link></comment>
<pub-id pub-id-type="pmid">22197120</pub-id></mixed-citation></ref><ref id="pone.0141256.ref018"><label>18</label><mixed-citation publication-type="journal">
<name><surname>Iellamo</surname><given-names>F</given-names></name>, <name><surname>Caminiti</surname><given-names>G</given-names></name>, <name><surname>Sposato</surname><given-names>B</given-names></name>, <name><surname>Vitale</surname><given-names>C</given-names></name>, <name><surname>Massaro</surname><given-names>M</given-names></name>, <name><surname>Rosano</surname><given-names>G</given-names></name>, <etal>et al</etal> (<year>2014</year>) <article-title>Effect of High-Intensity interval training versus moderate continuous training on 24-h blood pressure profile and insulin resistance in patients with chronic heart failure</article-title>. <source>Intern Emerg Med</source>
<volume>9</volume>: <fpage>547</fpage>&#x02013;<lpage>552</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/s11739-013-0980-4">10.1007/s11739-013-0980-4</ext-link></comment>
<pub-id pub-id-type="pmid">23857036</pub-id></mixed-citation></ref><ref id="pone.0141256.ref019"><label>19</label><mixed-citation publication-type="journal">
<name><surname>Iellamo</surname><given-names>F</given-names></name>, <name><surname>Manzi</surname><given-names>V</given-names></name>, <name><surname>Caminiti</surname><given-names>G</given-names></name>, <name><surname>Vitale</surname><given-names>C</given-names></name>, <name><surname>Castagna</surname><given-names>C</given-names></name>, <name><surname>Massaro</surname><given-names>M</given-names></name>, <etal>et al</etal> (<year>2013</year>) <article-title>Matched dose interval and continuous exercise training induce similar cardiorespiratory and metabolic adaptations in patients with heart failure</article-title>. <source>Int J Cardiol</source>
<volume>167</volume>: <fpage>2561</fpage>&#x02013;<lpage>2565</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.ijcard.2012.06.057">10.1016/j.ijcard.2012.06.057</ext-link></comment>
<pub-id pub-id-type="pmid">22769574</pub-id></mixed-citation></ref><ref id="pone.0141256.ref020"><label>20</label><mixed-citation publication-type="journal">
<name><surname>Dimopoulos</surname><given-names>S</given-names></name>, <name><surname>Anastasiou-Nana</surname><given-names>M</given-names></name>, <name><surname>Sakellariou</surname><given-names>D</given-names></name>, <name><surname>Drakos</surname><given-names>S</given-names></name>, <name><surname>Kapsimalakou</surname><given-names>S</given-names></name>, <name><surname>Maroulidis</surname><given-names>G</given-names></name>, <etal>et al</etal> (<year>2006</year>) <article-title>Effects of exercise rehabilitation program on heart rate recovery in patients with chronic heart failure</article-title>. <source>Eur J Cardiovasc Prev Rehabil</source>
<volume>13</volume>: <fpage>67</fpage>&#x02013;<lpage>73</lpage>.
<pub-id pub-id-type="pmid">16449866</pub-id></mixed-citation></ref><ref id="pone.0141256.ref021"><label>21</label><mixed-citation publication-type="journal">
<name><surname>Roditis</surname><given-names>P</given-names></name>, <name><surname>Dimopoulos</surname><given-names>S</given-names></name>, <name><surname>Sakellariou</surname><given-names>D</given-names></name>, <name><surname>Sarafoglou</surname><given-names>S</given-names></name>, <name><surname>Kaldara</surname><given-names>E</given-names></name>, <name><surname>Venetsanakos</surname><given-names>J</given-names></name>, <etal>et al</etal> (<year>2007</year>) <article-title>The effects of exercise training on the kinetics of oxygen uptake in patients with chronic heart failure</article-title>. <source>Eur J Cardiovasc Prev Rehabil</source>
<volume>14</volume>: <fpage>304</fpage>&#x02013;<lpage>311</lpage>.
<pub-id pub-id-type="pmid">17446812</pub-id></mixed-citation></ref><ref id="pone.0141256.ref022"><label>22</label><mixed-citation publication-type="journal">
<name><surname>Koufaki</surname><given-names>P</given-names></name>, <name><surname>Mercer</surname><given-names>TH</given-names></name>, <name><surname>George</surname><given-names>KP</given-names></name>, <name><surname>Nolan</surname><given-names>J</given-names></name> (<year>2014</year>) <article-title>Low-volume high-intensity interval training vs continuous aerobic cycling in patients with chronic heart failure: a pragmatic randomised clinical trial of feasibility and effectiveness</article-title>. <source>J Rehabil Med</source>
<volume>46</volume>: <fpage>348</fpage>&#x02013;<lpage>356</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.2340/16501977-1278">10.2340/16501977-1278</ext-link></comment>
<pub-id pub-id-type="pmid">24448650</pub-id></mixed-citation></ref><ref id="pone.0141256.ref023"><label>23</label><mixed-citation publication-type="journal">
<name><surname>Belardinelli</surname><given-names>R</given-names></name>, <name><surname>Georgiou</surname><given-names>D</given-names></name>, <name><surname>Cianci</surname><given-names>G</given-names></name>, <name><surname>Purcaro</surname><given-names>A</given-names></name> (<year>2012</year>) <article-title>10-year exercise training in chronic heart failure: a randomized controlled trial</article-title>. <source>J Am Coll Cardiol</source>
<volume>60</volume>: <fpage>1521</fpage>&#x02013;<lpage>1528</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.jacc.2012.06.036">10.1016/j.jacc.2012.06.036</ext-link></comment>
<pub-id pub-id-type="pmid">22999730</pub-id></mixed-citation></ref><ref id="pone.0141256.ref024"><label>24</label><mixed-citation publication-type="journal">
<name><surname>Fletcher</surname><given-names>GF</given-names></name>, <name><surname>Ades</surname><given-names>PA</given-names></name>, <name><surname>Kligfield</surname><given-names>P</given-names></name>, <name><surname>Arena</surname><given-names>R</given-names></name>, <name><surname>Balady</surname><given-names>GJ</given-names></name>, <name><surname>Bittner</surname><given-names>VA</given-names></name>, <etal>et al</etal> (<year>2013</year>) <article-title>Exercise standards for testing and training: a scientific statement from the American Heart Association</article-title>. <source>Circulation</source>
<volume>128</volume>: <fpage>873</fpage>&#x02013;<lpage>934</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1161/CIR.0b013e31829b5b44">10.1161/CIR.0b013e31829b5b44</ext-link></comment>
<pub-id pub-id-type="pmid">23877260</pub-id></mixed-citation></ref><ref id="pone.0141256.ref025"><label>25</label><mixed-citation publication-type="journal">
<name><surname>Durnin</surname><given-names>JV</given-names></name>, <name><surname>Womersley</surname><given-names>J</given-names></name> (<year>1974</year>) <article-title>Body fat assessed from total body density and its estimation from skinfold thickness: measurements on 481 men and women aged from 16 to 72 years</article-title>. <source>Br J Nutr</source>
<volume>32</volume>: <fpage>77</fpage>&#x02013;<lpage>97</lpage>.
<pub-id pub-id-type="pmid">4843734</pub-id></mixed-citation></ref><ref id="pone.0141256.ref026"><label>26</label><mixed-citation publication-type="journal">
<name><surname>Beaver</surname><given-names>WL</given-names></name>, <name><surname>Wasserman</surname><given-names>K</given-names></name>, <name><surname>Whipp</surname><given-names>BJ</given-names></name> (<year>1986</year>) <article-title>A new method for detecting anaerobic threshold by gas exchange</article-title>. <source>J Appl Physiol (1985)</source>
<volume>60</volume>: <fpage>2020</fpage>&#x02013;<lpage>2027</lpage>.<pub-id pub-id-type="pmid">3087938</pub-id></mixed-citation></ref><ref id="pone.0141256.ref027"><label>27</label><mixed-citation publication-type="book">
<name><surname>Wasserman</surname><given-names>K</given-names></name>, <name><surname>Hansen</surname><given-names>JE</given-names></name>, <name><surname>Sue</surname><given-names>DV</given-names></name>, <name><surname>Whipp</surname><given-names>BJ</given-names></name> (<year>1987</year>) <chapter-title>Principles of exercise testing and interpretation</chapter-title>
<publisher-loc>Philadelphia</publisher-loc>: <publisher-name>Lea &#x00026; Febiger</publisher-name>.</mixed-citation></ref><ref id="pone.0141256.ref028"><label>28</label><mixed-citation publication-type="journal">
<name><surname>Witte</surname><given-names>KK</given-names></name>, <name><surname>Cleland</surname><given-names>JG</given-names></name>, <name><surname>Clark</surname><given-names>AL</given-names></name> (<year>2006</year>) <article-title>Chronic heart failure, chronotropic incompetence, and the effects of beta blockade</article-title>. <source>Heart</source>
<volume>92</volume>: <fpage>481</fpage>&#x02013;<lpage>486</lpage>.
<pub-id pub-id-type="pmid">16159968</pub-id></mixed-citation></ref><ref id="pone.0141256.ref029"><label>29</label><mixed-citation publication-type="journal">
<name><surname>Thijssen</surname><given-names>DH</given-names></name>, <name><surname>Black</surname><given-names>MA</given-names></name>, <name><surname>Pyke</surname><given-names>KE</given-names></name>, <name><surname>Padilla</surname><given-names>J</given-names></name>, <name><surname>Atkinson</surname><given-names>G</given-names></name>, <name><surname>Harris</surname><given-names>RA</given-names></name>, <etal>et al</etal> (<year>2011</year>) <article-title>Assessment of flow-mediated dilation in humans: a methodological and physiological guideline</article-title>. <source>Am J Physiol Heart Circ Physiol</source>
<volume>300</volume>: <fpage>H2</fpage>&#x02013;<lpage>12</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1152/ajpheart.00471.2010">10.1152/ajpheart.00471.2010</ext-link></comment>
<pub-id pub-id-type="pmid">20952670</pub-id></mixed-citation></ref><ref id="pone.0141256.ref030"><label>30</label><mixed-citation publication-type="journal">
<name><surname>Naylor</surname><given-names>LH</given-names></name>, <name><surname>Weisbrod</surname><given-names>CJ</given-names></name>, <name><surname>O'Driscoll</surname><given-names>G</given-names></name>, <name><surname>Green</surname><given-names>DJ</given-names></name> (<year>2005</year>) <article-title>Measuring peripheral resistance and conduit arterial structure in humans using Doppler ultrasound</article-title>. <source>J Appl Physiol (1985)</source>
<volume>98</volume>: <fpage>2311</fpage>&#x02013;<lpage>2315</lpage>.<pub-id pub-id-type="pmid">15691903</pub-id></mixed-citation></ref><ref id="pone.0141256.ref031"><label>31</label><mixed-citation publication-type="journal">
<name><surname>Schreuder</surname><given-names>TH</given-names></name>, <name><surname>Nyakayiru</surname><given-names>J</given-names></name>, <name><surname>Houben</surname><given-names>J</given-names></name>, <name><surname>Thijssen</surname><given-names>DH</given-names></name>, <name><surname>Hopman</surname><given-names>MT</given-names></name> (<year>2014</year>) <article-title>Impact of hypoxic versus normoxic training on physical fitness and vasculature in diabetes</article-title>. <source>High Alt Med Biol</source>
<volume>15</volume>: <fpage>349</fpage>&#x02013;<lpage>355</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1089/ham.2013.1144">10.1089/ham.2013.1144</ext-link></comment>
<pub-id pub-id-type="pmid">25251929</pub-id></mixed-citation></ref><ref id="pone.0141256.ref032"><label>32</label><mixed-citation publication-type="journal">
<name><surname>de Groot</surname><given-names>E</given-names></name>, <name><surname>Hovingh</surname><given-names>GK</given-names></name>, <name><surname>Wiegman</surname><given-names>A</given-names></name>, <name><surname>Duriez</surname><given-names>P</given-names></name>, <name><surname>Smit</surname><given-names>AJ</given-names></name>, <name><surname>Fruchart</surname><given-names>JC</given-names></name>, <etal>et al</etal> (<year>2004</year>) <article-title>Measurement of arterial wall thickness as a surrogate marker for atherosclerosis</article-title>. <source>Circulation</source>
<volume>109</volume>: <fpage>III33</fpage>&#x02013;<lpage>38</lpage>.
<pub-id pub-id-type="pmid">15198964</pub-id></mixed-citation></ref><ref id="pone.0141256.ref033"><label>33</label><mixed-citation publication-type="other">Echocardiography ASo Guidelines of the American Society of Echocardiography.</mixed-citation></ref><ref id="pone.0141256.ref034"><label>34</label><mixed-citation publication-type="journal">
<name><surname>Ware</surname><given-names>JE</given-names><suffix>Jr</suffix></name>, <name><surname>Sherbourne</surname><given-names>CD</given-names></name> (<year>1992</year>) <article-title>The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection</article-title>. <source>Med Care</source>
<volume>30</volume>: <fpage>473</fpage>&#x02013;<lpage>483</lpage>.
<pub-id pub-id-type="pmid">1593914</pub-id></mixed-citation></ref><ref id="pone.0141256.ref035"><label>35</label><mixed-citation publication-type="journal">
<name><surname>Hobbs</surname><given-names>FD</given-names></name>, <name><surname>Kenkre</surname><given-names>JE</given-names></name>, <name><surname>Roalfe</surname><given-names>AK</given-names></name>, <name><surname>Davis</surname><given-names>RC</given-names></name>, <name><surname>Hare</surname><given-names>R</given-names></name>, <name><surname>Davies</surname><given-names>MK</given-names></name> (<year>2002</year>) <article-title>Impact of heart failure and left ventricular systolic dysfunction on quality of life: a cross-sectional study comparing common chronic cardiac and medical disorders and a representative adult population</article-title>. <source>Eur Heart J</source>
<volume>23</volume>: <fpage>1867</fpage>&#x02013;<lpage>1876</lpage>.
<pub-id pub-id-type="pmid">12445536</pub-id></mixed-citation></ref><ref id="pone.0141256.ref036"><label>36</label><mixed-citation publication-type="journal">
<name><surname>Rector</surname><given-names>TS</given-names></name>, <name><surname>Cohn</surname><given-names>JN</given-names></name> (<year>1992</year>) <article-title>Assessment of patient outcome with the Minnesota Living with Heart Failure questionnaire: reliability and validity during a randomized, double-blind, placebo-controlled trial of pimobendan. Pimobendan Multicenter Research Group</article-title>. <source>Am Heart J</source>
<volume>124</volume>: <fpage>1017</fpage>&#x02013;<lpage>1025</lpage>.
<pub-id pub-id-type="pmid">1529875</pub-id></mixed-citation></ref><ref id="pone.0141256.ref037"><label>37</label><mixed-citation publication-type="journal">
<name><surname>Borg</surname><given-names>G</given-names></name>, <name><surname>Hassmen</surname><given-names>P</given-names></name>, <name><surname>Lagerstrom</surname><given-names>M</given-names></name> (<year>1987</year>) <article-title>Perceived exertion related to heart rate and blood lactate during arm and leg exercise</article-title>. <source>Eur J Appl Physiol Occup Physiol</source>
<volume>56</volume>: <fpage>679</fpage>&#x02013;<lpage>685</lpage>.
<pub-id pub-id-type="pmid">3678222</pub-id></mixed-citation></ref><ref id="pone.0141256.ref038"><label>38</label><mixed-citation publication-type="journal">
<name><surname>Atkinson</surname><given-names>G</given-names></name>, <name><surname>Batterham</surname><given-names>AM</given-names></name> (<year>2013</year>) <article-title>Allometric scaling of diameter change in the original flow-mediated dilation protocol</article-title>. <source>Atherosclerosis</source>
<volume>226</volume>: <fpage>425</fpage>&#x02013;<lpage>427</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.atherosclerosis.2012.11.027">10.1016/j.atherosclerosis.2012.11.027</ext-link></comment>
<pub-id pub-id-type="pmid">23261170</pub-id></mixed-citation></ref><ref id="pone.0141256.ref039"><label>39</label><mixed-citation publication-type="journal">
<name><surname>O'Connor</surname><given-names>CM</given-names></name>, <name><surname>Whellan</surname><given-names>DJ</given-names></name>, <name><surname>Lee</surname><given-names>KL</given-names></name>, <name><surname>Keteyian</surname><given-names>SJ</given-names></name>, <name><surname>Cooper</surname><given-names>LS</given-names></name>, <name><surname>Ellis</surname><given-names>SJ</given-names></name>, <etal>et al</etal> (<year>2009</year>) <article-title>Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial</article-title>. <source>JAMA</source>
<volume>301</volume>: <fpage>1439</fpage>&#x02013;<lpage>1450</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1001/jama.2009.454">10.1001/jama.2009.454</ext-link></comment>
<pub-id pub-id-type="pmid">19351941</pub-id></mixed-citation></ref><ref id="pone.0141256.ref040"><label>40</label><mixed-citation publication-type="journal">
<name><surname>Garber</surname><given-names>CE</given-names></name>, <name><surname>Blissmer</surname><given-names>B</given-names></name>, <name><surname>Deschenes</surname><given-names>MR</given-names></name>, <name><surname>Franklin</surname><given-names>BA</given-names></name>, <name><surname>Lamonte</surname><given-names>MJ</given-names></name>, <name><surname>Lee</surname><given-names>IM</given-names></name>, <etal>et al</etal> (<year>2011</year>) <article-title>American College of Sports Medicine position stand. Quantity and quality of exercise for developing and maintaining cardiorespiratory, musculoskeletal, and neuromotor fitness in apparently healthy adults: guidance for prescribing exercise</article-title>. <source>Med Sci Sports Exerc</source>
<volume>43</volume>: <fpage>1334</fpage>&#x02013;<lpage>1359</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1249/MSS.0b013e318213fefb">10.1249/MSS.0b013e318213fefb</ext-link></comment>
<pub-id pub-id-type="pmid">21694556</pub-id></mixed-citation></ref><ref id="pone.0141256.ref041"><label>41</label><mixed-citation publication-type="journal">
<name><surname>Bouchard</surname><given-names>C</given-names></name>, <name><surname>An</surname><given-names>P</given-names></name>, <name><surname>Rice</surname><given-names>T</given-names></name>, <name><surname>Skinner</surname><given-names>JS</given-names></name>, <name><surname>Wilmore</surname><given-names>JH</given-names></name>, <name><surname>Gagnon</surname><given-names>J</given-names></name>, <etal>et al</etal> (<year>1999</year>) <article-title>Familial aggregation of VO(2max) response to exercise training: results from the HERITAGE Family Study</article-title>. <source>J Appl Physiol (1985)</source>
<volume>87</volume>: <fpage>1003</fpage>&#x02013;<lpage>1008</lpage>.<pub-id pub-id-type="pmid">10484570</pub-id></mixed-citation></ref><ref id="pone.0141256.ref042"><label>42</label><mixed-citation publication-type="journal">
<name><surname>Kemps</surname><given-names>HM</given-names></name>, <name><surname>Schep</surname><given-names>G</given-names></name>, <name><surname>de Vries</surname><given-names>WR</given-names></name>, <name><surname>Schmikli</surname><given-names>SL</given-names></name>, <name><surname>Zonderland</surname><given-names>ML</given-names></name>, <name><surname>Thijssen</surname><given-names>EJ</given-names></name>, <etal>et al</etal> (<year>2008</year>) <article-title>Predicting effects of exercise training in patients with heart failure secondary to ischemic or idiopathic dilated cardiomyopathy</article-title>. <source>Am J Cardiol</source>
<volume>102</volume>: <fpage>1073</fpage>&#x02013;<lpage>1078</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.amjcard.2008.05.054">10.1016/j.amjcard.2008.05.054</ext-link></comment>
<pub-id pub-id-type="pmid">18929712</pub-id></mixed-citation></ref><ref id="pone.0141256.ref043"><label>43</label><mixed-citation publication-type="journal">
<name><surname>Meyer</surname><given-names>K</given-names></name>, <name><surname>Gornandt</surname><given-names>L</given-names></name>, <name><surname>Schwaibold</surname><given-names>M</given-names></name>, <name><surname>Westbrook</surname><given-names>S</given-names></name>, <name><surname>Hajric</surname><given-names>R</given-names></name>, <name><surname>Peters</surname><given-names>K</given-names></name>, <etal>et al</etal> (<year>1997</year>) <article-title>Predictors of response to exercise training in severe chronic congestive heart failure</article-title>. <source>Am J Cardiol</source>
<volume>80</volume>: <fpage>56</fpage>&#x02013;<lpage>60</lpage>.
<pub-id pub-id-type="pmid">9205020</pub-id></mixed-citation></ref><ref id="pone.0141256.ref044"><label>44</label><mixed-citation publication-type="journal">
<name><surname>Schmid</surname><given-names>JP</given-names></name>, <name><surname>Zurek</surname><given-names>M</given-names></name>, <name><surname>Saner</surname><given-names>H</given-names></name> (<year>2013</year>) <article-title>Chronotropic incompetence predicts impaired response to exercise training in heart failure patients with sinus rhythm</article-title>. <source>Eur J Prev Cardiol</source>
<volume>20</volume>: <fpage>585</fpage>&#x02013;<lpage>592</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1177/2047487312444368">10.1177/2047487312444368</ext-link></comment>
<pub-id pub-id-type="pmid">22492866</pub-id></mixed-citation></ref><ref id="pone.0141256.ref045"><label>45</label><mixed-citation publication-type="journal">
<name><surname>Smart</surname><given-names>NA</given-names></name>, <name><surname>Dieberg</surname><given-names>G</given-names></name>, <name><surname>Giallauria</surname><given-names>F</given-names></name> (<year>2013</year>) <article-title>Intermittent versus continuous exercise training in chronic heart failure: a meta-analysis</article-title>. <source>Int J Cardiol</source>
<volume>166</volume>: <fpage>352</fpage>&#x02013;<lpage>358</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.ijcard.2011.10.075">10.1016/j.ijcard.2011.10.075</ext-link></comment>
<pub-id pub-id-type="pmid">22100179</pub-id></mixed-citation></ref><ref id="pone.0141256.ref046"><label>46</label><mixed-citation publication-type="journal">
<name><surname>Haykowsky</surname><given-names>MJ</given-names></name>, <name><surname>Timmons</surname><given-names>MP</given-names></name>, <name><surname>Kruger</surname><given-names>C</given-names></name>, <name><surname>McNeely</surname><given-names>M</given-names></name>, <name><surname>Taylor</surname><given-names>DA</given-names></name>, <name><surname>Clark</surname><given-names>AM</given-names></name> (<year>2013</year>) <article-title>Meta-analysis of aerobic interval training on exercise capacity and systolic function in patients with heart failure and reduced ejection fractions</article-title>. <source>Am J Cardiol</source>
<volume>111</volume>: <fpage>1466</fpage>&#x02013;<lpage>1469</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.amjcard.2013.01.303">10.1016/j.amjcard.2013.01.303</ext-link></comment>
<pub-id pub-id-type="pmid">23433767</pub-id></mixed-citation></ref><ref id="pone.0141256.ref047"><label>47</label><mixed-citation publication-type="journal">
<name><surname>Lavie</surname><given-names>CJ</given-names></name>, <name><surname>Arena</surname><given-names>R</given-names></name>, <name><surname>Earnest</surname><given-names>CP</given-names></name> (<year>2013</year>) <article-title>High-intensity interval training in patients with cardiovascular diseases and heart transplantation</article-title>. <source>J Heart Lung Transplant</source>
<volume>32</volume>: <fpage>1056</fpage>&#x02013;<lpage>1058</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.healun.2013.08.001">10.1016/j.healun.2013.08.001</ext-link></comment>
<pub-id pub-id-type="pmid">24135041</pub-id></mixed-citation></ref><ref id="pone.0141256.ref048"><label>48</label><mixed-citation publication-type="journal">
<name><surname>Buchheit</surname><given-names>M</given-names></name>, <name><surname>Laursen</surname><given-names>PB</given-names></name> (<year>2013</year>) <article-title>High-intensity interval training, solutions to the programming puzzle: Part I: cardiopulmonary emphasis</article-title>. <source>Sports Med</source>
<volume>43</volume>: <fpage>313</fpage>&#x02013;<lpage>338</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/s40279-013-0029-x">10.1007/s40279-013-0029-x</ext-link></comment>
<pub-id pub-id-type="pmid">23539308</pub-id></mixed-citation></ref><ref id="pone.0141256.ref049"><label>49</label><mixed-citation publication-type="journal">
<name><surname>Koukoui</surname><given-names>F</given-names></name>, <name><surname>Desmoulin</surname><given-names>F</given-names></name>, <name><surname>Lairy</surname><given-names>G</given-names></name>, <name><surname>Bleinc</surname><given-names>D</given-names></name>, <name><surname>Boursiquot</surname><given-names>L</given-names></name>, <name><surname>Galinier</surname><given-names>M</given-names></name>, <etal>et al</etal> (<year>2015</year>) <article-title>Benefits of cardiac rehabilitation in heart failure patients according to etiology: INCARD French study</article-title>. <source>Medicine (Baltimore)</source>
<volume>94</volume>: <fpage>e544</fpage>.<pub-id pub-id-type="pmid">25700319</pub-id></mixed-citation></ref><ref id="pone.0141256.ref050"><label>50</label><mixed-citation publication-type="journal">
<name><surname>Ramos</surname><given-names>JS</given-names></name>, <name><surname>Dalleck</surname><given-names>LC</given-names></name>, <name><surname>Tjonna</surname><given-names>AE</given-names></name>, <name><surname>Beetham</surname><given-names>KS</given-names></name>, <name><surname>Coombes</surname><given-names>JS</given-names></name> (<year>2015</year>) <article-title>The impact of high-intensity interval training versus moderate-intensity continuous training on vascular function: a systematic review and meta-analysis</article-title>. <source>Sports Med</source>
<volume>45</volume>: <fpage>679</fpage>&#x02013;<lpage>692</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/s40279-015-0321-z">10.1007/s40279-015-0321-z</ext-link></comment>
<pub-id pub-id-type="pmid">25771785</pub-id></mixed-citation></ref><ref id="pone.0141256.ref051"><label>51</label><mixed-citation publication-type="journal">
<name><surname>Green</surname><given-names>DJ</given-names></name>, <name><surname>Eijsvogels</surname><given-names>T</given-names></name>, <name><surname>Bouts</surname><given-names>YM</given-names></name>, <name><surname>Maiorana</surname><given-names>AJ</given-names></name>, <name><surname>Naylor</surname><given-names>LH</given-names></name>, <name><surname>Scholten</surname><given-names>RR</given-names></name>, <etal>et al</etal> (<year>2014</year>) <article-title>Exercise training and artery function in humans: nonresponse and its relationship to cardiovascular risk factors</article-title>. <source>J Appl Physiol (1985)</source>
<volume>117</volume>: <fpage>345</fpage>&#x02013;<lpage>352</lpage>.<pub-id pub-id-type="pmid">24947027</pub-id></mixed-citation></ref><ref id="pone.0141256.ref052"><label>52</label><mixed-citation publication-type="journal">
<name><surname>Skaug</surname><given-names>EA</given-names></name>, <name><surname>Aspenes</surname><given-names>ST</given-names></name>, <name><surname>Oldervoll</surname><given-names>L</given-names></name>, <name><surname>Morkedal</surname><given-names>B</given-names></name>, <name><surname>Vatten</surname><given-names>L</given-names></name>, <name><surname>Wisloff</surname><given-names>U</given-names></name>, <etal>et al</etal> (<year>2013</year>) <article-title>Age and gender differences of endothelial function in 4739 healthy adults: the HUNT3 Fitness Study</article-title>. <source>Eur J Prev Cardiol</source>
<volume>20</volume>: <fpage>531</fpage>&#x02013;<lpage>540</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1177/2047487312444234">10.1177/2047487312444234</ext-link></comment>
<pub-id pub-id-type="pmid">22456692</pub-id></mixed-citation></ref><ref id="pone.0141256.ref053"><label>53</label><mixed-citation publication-type="journal">
<name><surname>Briasoulis</surname><given-names>A</given-names></name>, <name><surname>Tousoulis</surname><given-names>D</given-names></name>, <name><surname>Androulakis</surname><given-names>ES</given-names></name>, <name><surname>Papageorgiou</surname><given-names>N</given-names></name>, <name><surname>Latsios</surname><given-names>G</given-names></name>, <name><surname>Stefanadis</surname><given-names>C</given-names></name> (<year>2012</year>) <article-title>Endothelial dysfunction and atherosclerosis: focus on novel therapeutic approaches</article-title>. <source>Recent Pat Cardiovasc Drug Discov</source>
<volume>7</volume>: <fpage>21</fpage>&#x02013;<lpage>32</lpage>.
<pub-id pub-id-type="pmid">22280336</pub-id></mixed-citation></ref><ref id="pone.0141256.ref054"><label>54</label><mixed-citation publication-type="journal">
<name><surname>Benda</surname><given-names>NM</given-names></name>, <name><surname>Seeger</surname><given-names>JP</given-names></name>, <name><surname>van Lier</surname><given-names>DP</given-names></name>, <name><surname>Bellersen</surname><given-names>L</given-names></name>, <name><surname>van Dijk</surname><given-names>AP</given-names></name>, <name><surname>Hopman</surname><given-names>MT</given-names></name>, <etal>et al</etal> (<year>2015</year>) <article-title>Heart failure patients demonstrate impaired changes in brachial artery blood flow and shear rate pattern during moderate-intensity cycle exercise</article-title>. <source>Exp Physiol</source>.</mixed-citation></ref><ref id="pone.0141256.ref055"><label>55</label><mixed-citation publication-type="journal">
<name><surname>Taylor</surname><given-names>RS</given-names></name>, <name><surname>Sagar</surname><given-names>VA</given-names></name>, <name><surname>Davies</surname><given-names>EJ</given-names></name>, <name><surname>Briscoe</surname><given-names>S</given-names></name>, <name><surname>Coats</surname><given-names>AJ</given-names></name>, <name><surname>Dalal</surname><given-names>H</given-names></name>, <etal>et al</etal> (<year>2014</year>) <article-title>Exercise-based rehabilitation for heart failure</article-title>. <source>Cochrane Database Syst Rev</source>
<volume>4</volume>: <fpage>Cd003331</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1002/14651858.CD003331.pub4">10.1002/14651858.CD003331.pub4</ext-link></comment>
<pub-id pub-id-type="pmid">24771460</pub-id></mixed-citation></ref><ref id="pone.0141256.ref056"><label>56</label><mixed-citation publication-type="journal">
<name><surname>Nilsson</surname><given-names>BB</given-names></name>, <name><surname>Westheim</surname><given-names>A</given-names></name>, <name><surname>Risberg</surname><given-names>MA</given-names></name> (<year>2008</year>) <article-title>Effects of group-based high-intensity aerobic interval training in patients with chronic heart failure</article-title>. <source>Am J Cardiol</source>
<volume>102</volume>: <fpage>1361</fpage>&#x02013;<lpage>1365</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.amjcard.2008.07.016">10.1016/j.amjcard.2008.07.016</ext-link></comment>
<pub-id pub-id-type="pmid">18993156</pub-id></mixed-citation></ref><ref id="pone.0141256.ref057"><label>57</label><mixed-citation publication-type="journal">
<name><surname>Aksoy</surname><given-names>S</given-names></name>, <name><surname>Findikoglu</surname><given-names>G</given-names></name>, <name><surname>Ardic</surname><given-names>F</given-names></name>, <name><surname>Rota</surname><given-names>S</given-names></name>, <name><surname>Dursunoglu</surname><given-names>D</given-names></name> (<year>2015</year>) <article-title>Effect of 10-Week Supervised Moderate-Intensity Intermittent vs. Continuous Aerobic Exercise Programs on Vascular Adhesion Molecules in Patients with Heart Failure</article-title>. <source>Am J Phys Med Rehabil</source>.</mixed-citation></ref><ref id="pone.0141256.ref058"><label>58</label><mixed-citation publication-type="journal">
<name><surname>Chrysohoou</surname><given-names>C</given-names></name>, <name><surname>Tsitsinakis</surname><given-names>G</given-names></name>, <name><surname>Vogiatzis</surname><given-names>I</given-names></name>, <name><surname>Cherouveim</surname><given-names>E</given-names></name>, <name><surname>Antoniou</surname><given-names>C</given-names></name>, <name><surname>Tsiantilas</surname><given-names>A</given-names></name>, <etal>et al</etal> (<year>2014</year>) <article-title>High intensity, interval exercise improves quality of life of patients with chronic heart failure: a randomized controlled trial</article-title>. <source>QJM</source>
<volume>107</volume>: <fpage>25</fpage>&#x02013;<lpage>32</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1093/qjmed/hct194">10.1093/qjmed/hct194</ext-link></comment>
<pub-id pub-id-type="pmid">24082155</pub-id></mixed-citation></ref><ref id="pone.0141256.ref059"><label>59</label><mixed-citation publication-type="journal">
<name><surname>Swank</surname><given-names>AM</given-names></name>, <name><surname>Horton</surname><given-names>J</given-names></name>, <name><surname>Fleg</surname><given-names>JL</given-names></name>, <name><surname>Fonarow</surname><given-names>GC</given-names></name>, <name><surname>Keteyian</surname><given-names>S</given-names></name>, <name><surname>Goldberg</surname><given-names>L</given-names></name>, <etal>et al</etal> (<year>2012</year>) <article-title>Modest increase in peak VO2 is related to better clinical outcomes in chronic heart failure patients: results from heart failure and a controlled trial to investigate outcomes of exercise training</article-title>. <source>Circ Heart Fail</source>
<volume>5</volume>: <fpage>579</fpage>&#x02013;<lpage>585</lpage>.
<pub-id pub-id-type="pmid">22773109</pub-id></mixed-citation></ref><ref id="pone.0141256.ref060"><label>60</label><mixed-citation publication-type="journal">
<name><surname>Barbour</surname><given-names>KA</given-names></name>, <name><surname>Miller</surname><given-names>NH</given-names></name> (<year>2008</year>) <article-title>Adherence to exercise training in heart failure: a review</article-title>. <source>Heart Fail Rev</source>
<volume>13</volume>: <fpage>81</fpage>&#x02013;<lpage>89</lpage>.
<pub-id pub-id-type="pmid">18008161</pub-id></mixed-citation></ref></ref-list></back></article>